Review Article

Medical Progress

Chronic Autoimmune Thyroiditis

Colin M. Dayan, M.D., Ph.D., and Gilbert H. Daniels, M.D.

N Engl J Med 1996; 335:99-107July 11, 1996DOI: 10.1056/NEJM199607113350206

Article

In 1912, Hashimoto described four women in whom the thyroid gland was enlarged and appeared to have been transformed into lymphoid tissue (“struma lymphomatosa”).1 Although the patients were not initially hypothyroid, they became so after thyroid surgery. Over 40 years later, the presence of antithyroid antibodies was reported in patients with this disorder.2 Hashimoto's disease, or Hashimoto's thyroiditis, is now recognized as a form of chronic autoimmune thyroiditis.

There is no internationally accepted classification of autoimmune thyroid diseases.3 Some investigators consider autoimmune thyroiditis a histologic diagnosis that can be subdivided into lymphocytic thyroiditis, if only lymphocytic infiltration is present, and Hashimoto's thyroiditis, if atrophy and eosinophilic changes in thyroid cells and fibrosis are also seen.4 Chronic autoimmune thyroiditis has two clinical forms: a goitrous form often referred to as Hashimoto's disease, and an atrophic form called atrophic thyroiditis. Both are characterized by the presence of thyroid autoantibodies in serum and by varying degrees of thyroid dysfunction; they differ only in the absence or presence of goiter.

Graves' disease — diffuse goiter with hyperthyroidism, ophthalmopathy, or both — is a related autoimmune thyroid disease but not autoimmune thyroiditis.5 Silent (or painless) thyroiditis is a transient disorder characterized by lymphocytic thyroiditis, painless goiter, and hyperthyroidism, hypothyroidism, or both. When this condition occurs after parturition, it is referred to as postpartum thyroiditis. Both silent thyroiditis and postpartum thyroiditis are now believed to be manifestations of chronic autoimmune thyroiditis.6 Subacute (de Quervain's) thyroiditis, which is a postviral inflammation of the thyroid characterized by pain and tenderness, is not a form of autoimmune thyroiditis.

Histologic Features

Goitrous autoimmune thyroiditis is characterized by diffuse lymphocytic infiltration with occasional germinal centers, thyroid follicles of reduced size containing sparse colloid, and fibrosis (Figure 1AFigure 1Microscopical Section of Thyroid Tissue Showing Typical Features of Chronic Autoimmune Thyroiditis (Panel A, Hematoxylin and Eosin, ×175; Panel B, Hematoxylin and Eosin, ×550). and Figure 1B). Although the follicles are small, the individual thyroid cells often appear enlarged and contain cytoplasm that is granular and pink (oxyphil change); such cells are known as Hürthle or Askanazy cells.7 When lymphocytic infiltration alone is the only histologic finding, chronic autoimmune thyroiditis can be diagnosed with confidence only if the patient has high serum titers of antithyroid autoantibodies.

In atrophic autoimmune thyroiditis, the thyroid gland is small, with lymphocytic infiltration and fibrous tissue replacing the thyroid parenchyma. Although it is tempting to think of atrophic autoimmune thyroiditis as the end stage of goitrous disease, little histologic progression has been noted in patients undergoing second biopsies up to 20 years after the first.8,9

Pathogenesis

T-Cell Activation

The autoimmune process is believed to begin with the activation of CD4 (helper) T lymphocytes specific for thyroid antigens.10 Such antigen-specific T cells have been isolated from thyroid tissue from patients with Graves' disease but not yet from thyroid tissue from those with chronic autoimmune thyroiditis.11 How these cells become activated is not known; current thinking is divided between two hypotheses. One hypothesis is that infection with a virus or bacterium that contains a protein similar to a thyroid protein may result in the activation of thyroid-specific T cells, a concept referred to as molecular mimicry. Such a cross-reaction would be expected to activate only T cells specific for the cross-reactive sequence, thus involving only a limited number of T-cell clones. Oligoclonality of lymphocytes has been reported in thyroid tissue from patients with autoimmune thyroiditis,12 but the finding remains controversial.13 Serologic evidence of recent bacterial and viral infection,14,15 as well as an increased frequency of antiretroviral antibodies not specific for the human immunodeficiency virus,16 has been reported in patients with chronic autoimmune thyroiditis, but the evidence that an infectious agent precipitated the condition remains unconvincing.17

The alternative hypothesis is that the thyroid epithelial cells present their own intracellular proteins to helper T cells. This view is supported by the finding that thyroid cells in patients with autoimmune thyroiditis, but not normal thyroid cells, express major-histocompatibility-complex (MHC) class II proteins (HLA-DR, HLA-DP, and HLA-DQ),18 molecules that are required for antigen presentation to CD4 T cells. Interferon gamma, a cytokine product of activated T cells, can induce the expression of MHC class II molecules by thyroid cells.19 Hence, interferon gamma released from activated T cells may induce the expression of MHC class II molecules by thyroid cells, thereby leading to T-cell restimulation by thyroid cells and perpetuation of the autoimmune process.11,20,21 The mechanism underlying the initial activation of T cells in this model is not clear but may be less antigen-specific than in molecular mimicry, since the thyroid itself promotes further expansion of the relevant population of T cells. This scheme is likely to be an oversimplification, because many non-MHC costimulatory molecules are required for the activation of T cells, and thyroid cells have yet to be shown to express such molecules.22

Generation of an Autoantibody Response

Once activated, self-reactive CD4 T cells can stimulate autoreactive B cells to be recruited into the thyroid and to secrete thyroid antibodies. The three main target antigens for thyroid antibodies are thyroglobulin, the storage protein for thyroid hormones; the thyroid microsomal antigen, which has been identified as thyroid peroxidase,23 the rate-limiting enzyme in thyroid hormone biosynthesis; and the thyrotropin receptor. Antibodies to other thyroid antigens and thyroid-growth–promoting immunoglobulins distinct from thyrotropin-receptor–stimulating antibodies have been described but not fully characterized.24

Mechanism of Hypothyroidism

Activated CD4 T cells recruit cytotoxic (CD8) T cells as well as B cells into the thyroid.25 The direct killing of thyroid cells by CD8 cells is believed to be the main mechanism responsible for hypothyroidism. However, thyroid autoantibodies may also have a pathogenic role. Anti–thyroid peroxidase antibodies inhibit the activity of thyroid peroxidase in vitro but are unlikely to have a primary effect in vivo.26 Some patients have cytotoxic antibodies capable of fixing complement and causing thyroid-cell lysis,27-29 and terminal complement complexes have been detected on thyroid cells.30 Antibody-dependent, cell-mediated cytotoxicity involving natural killer cells has also been described. The relative contributions of these various mechanisms of thyroid destruction in vivo remain uncertain.

Anti–thyrotropin-receptor antibodies may also contribute to hypothyroidism by blocking the action of thyrotropin. These antibodies have been reported in about 10 percent of patients with goitrous autoimmune thyroiditis and in about 20 percent of those with atrophic autoimmune thyroiditis.31-33 How often anti–thyrotropin-receptor antibodies are the sole cause of hypothyroidism is uncertain. Among adults in whom these antibodies spontaneously disappear during treatment with thyroxine, only 40 percent remain euthyroid after therapy has been discontinued,33 suggesting that thyrotropin-receptor–blocking antibodies contribute to hypothyroidism in about 5 to 10 percent of patients with chronic autoimmune thyroiditis.

Predisposing Factors

Genetic Factors

Thyroid autoimmunity is familial. Up to 50 percent of the first-degree relatives of patients with chronic autoimmune thyroiditis have thyroid antibodies, apparently inherited as a dominant trait.34,35 Graves' disease or chronic autoimmune thyroiditis may develop in affected relatives.36,37

In early studies in whites, the HLA-B8, DR3 haplotype was associated with atrophic autoimmune thyroiditis, and HLA-DR5 with goitrous autoimmune thyroiditis, suggesting that the two disorders have separate causes.10 In Japanese persons, HLA-DR2 or HLA-DQ1 appears to be protective.38,39 These associations are weak, however, and not consistently reproducible. Furthermore, specific HLA loci often fail to segregate with the presence of thyroid autoantibodies or the expression of disease within families.35,40 The high prevalence of thyroid autoimmunity in patients with Down's syndrome (16 to 28 percent)41 and in those with familial Alzheimer's disease42 has drawn attention to chromosome 21. However, up to 50 percent of patients with Turner's syndrome, particularly those with an X isochromosome, also have chronic autoimmune thyroiditis.43

Exogenous Factors

The prevalence of chronic autoimmune thyroiditis is correlated with iodine intake, with the highest prevalence in countries with the highest intake of iodine, such as the United States and Japan.44 Iodine supplementation in areas where iodine is deficient increases the prevalence of lymphocytic infiltration of the thyroid threefold,45 and the prevalence of positive serum tests for thyroid antibodies in such areas rises to over 40 percent within 0.5 to 5 years.46 In areas with sufficient iodine, further supplementation can induce reversible hypothyroidism. However, iodine reduces thyroid secretion in both subjects with thyroid autoantibodies and those without thyroid autoantibodies, suggesting that it acts by inhibiting the biosynthesis and release of thyroid hormone rather than by augmenting thyroid autoimmunity.47,48 Euthyroid patients with (subclinical) chronic autoimmune thyroiditis would be expected to be more susceptible to the antithyroid effects of iodine because of the inability of the thyroid to escape from the inhibitory effects of excess iodine on the biosynthesis of thyroid hormone (Wolff–Chaikoff effect).49 Amiodarone is a common cause of iodine-induced hypothyroidism because of its long half-life and high iodine content (35 percent by weight). Amiodarone-induced hypothyroidism usually occurs within 18 months after the initiation of therapy and is seven times more likely to develop in patients with thyroid antibodies than in those without thyroid antibodies.50

Hypothyroidism, which is often transient, develops in up to one third of patients treated with lithium and is more common in patients with thyroid antibodies than in those without antibodies.51,52 As with iodine, this condition may represent a direct effect of lithium on the release of thyroid hormone, but thyroid autoantibodies are found in a larger proportion of lithium-treated patients than normal subjects (24 percent vs. 12 percent).52

Thyroid autoantibodies, hypothyroidism, or less commonly, Graves' disease or transient hyperthyroidism may develop in patients with cancer, myeloproliferative or myelodysplastic syndromes, or chronic viral hepatitis who are treated with interferon alfa.53-55 The antibodies are detected in up to 20 percent of patients treated with interferon alfa, and clinical hypothyroidism develops in about 5 percent.53,55,56 Both effects are usually reversible when therapy is stopped. Treatment with interleukin-2 or granulocyte–macrophage colony-stimulating factor has similar effects.57,58 Patients with thyroid antibodies before treatment are more likely to have thyroid dysfunction during treatment.59 Treatment with interferon gamma, in contrast, does not induce chronic autoimmune thyroiditis, despite its proposed role in the pathogenesis of this disease.60

Prevalence

Chronic autoimmune thyroiditis is common, but the prevalence reported in studies varies with the criteria for diagnosis, the decade when the study was performed, and the patients studied. Diagnostic criteria have included a positive test for thyroid autoantibodies in serum, an elevated serum thyrotropin concentration, and the presence of lymphocytic infiltration of the thyroid at autopsy. Forty to 45 percent of women and 20 percent of men in the United Kingdom and the United States have some degree of focal thyroiditis at autopsy (1 to 10 foci per square centimeter). When more severe thyroiditis (more than 40 foci per square centimeter) is considered, the prevalence declines to 5 to 15 percent in women and 1 to 5 percent in men.61,62

Patients with other thyroid diseases, such as multinodular goiter and thyroid cancer, may have low serum titers of thyroid antibodies, especially anti–thyroid peroxidase antibodies, but high titers — for example, in excess of 1:6400 in the case of antithyroid microsomal antibodies, or 200 IU per milliliter in the case of anti–thyroid peroxidase antibodies — are strongly suggestive of chronic autoimmune thyroiditis63,64 or Graves' disease. Titers of antithyroid microsomal antibodies higher than 1:100 were found in 10 to 13 percent of women and 3 percent of men in community surveys in Whickham, United Kingdom, and New South Wales, Australia,65,66 but only 1 percent of the subjects had titers higher than 1:6400. The prevalence of positive tests for thyroid antibodies increases with age, with frequencies as high as 33 percent in women 70 years old or older.67

In areas with sufficient iodine, an elevated serum thyrotropin concentration is often viewed as evidence of chronic autoimmune thyroiditis, and in studies in these areas, at least half the subjects with serum thyrotropin values higher than 5 mU per liter and 80 percent with values higher than 10 mU per liter have thyroid antibodies.65,68 In community surveys in Detroit,69 Baltimore,70 and Whickham65 and a survey of general practices in Birmingham, United Kingdom,68 8 to 17 percent of subjects older than 55 to 60 years had subclinical hypothyroidism (a high serum thyrotropin concentration [>5 mU per liter] and a normal serum thyroxine concentration), and 3 to 7 percent had serum thyrotropin values higher than 10 mU per liter.69,71 Despite these high figures, the prevalence of overt hypothyroidism (high serum thyrotropin and low serum thyroxine concentrations) was only 1.4 percent in women in Whickham and only about 3 percent in elderly women in Framingham, Massachusetts.71 The rates of subclinical or overt hypothyroidism are up to seven times higher in women than in men and up to two times higher in whites than in blacks.69,72

Clinical Presentation

Patients with chronic autoimmune thyroiditis present with hypothyroidism, goiter, or both. Women are five to seven times more likely to be affected than men, and a higher proportion of women have goiter.72-74 In the Whickham survey, only 9 percent of the subjects in whom hypothyroidism developed were under the age of 45 years. After the age of 45, the hazard (incidence) rate for the development of hypothyroidism increased with age (Figure 2Figure 2Age-Specific Hazard Rates for the Development of Hypothyroidism and Hyperthyroidism in Women in Whickham, United Kingdom.), with 51 percent of cases diagnosed in subjects between 45 and 64 years of age. The overall mean age at the time of the diagnosis was 59 years among the women and 58 years among the men.72 Chronic autoimmune thyroiditis is rare in children younger than five years of age, but it does occur in children and accounts for 40 percent or more of cases of goiter in adolescents.75

In classic Hashimoto's disease (goitrous autoimmune thyroiditis), the thyroid gland, including the pyramidal lobe if present, is diffusely enlarged, its consistency firm, and its surface often irregular. In up to 13 percent of cases, particularly in the elderly, extensive fibrosis results in an enlarging, hard goiter that may be confused with malignant disease.76 The increase in the size of the thyroid ranges from minimal to massive (up to 350 g), but in most cases the thyroid weighs about 40 g (two to three times the normal weight).77,78 Compression of the trachea, esophagus, or recurrent laryngeal nerves is very rare. Such changes or rapid growth of the goiter can occur, particularly in the fibrous variant, but these findings should also raise suspicion of thyroid lymphoma or carcinoma. Although a feeling of tightness in the neck is common, thyroid pain and tenderness are rare.79 The goiter may be asymmetric and in a euthyroid patient may be mistaken for a solitary nodule or multinodular goiter. By definition, patients with atrophic autoimmune thyroiditis have no goiter. Thyroid-associated ophthalmopathy can occur in patients with chronic autoimmune thyroiditis but is far more common in those with Graves' disease.

Diagnostic Studies

Laboratory Findings

When chronic autoimmune thyroiditis is suspected clinically, a test for thyroid antibodies and measurement of the serum thyrotropin concentration are generally sufficient to confirm the diagnosis. The hallmark of chronic autoimmune thyroiditis is the presence of thyroid-specific autoantibodies in serum. Antithyroglobulin antibodies have been reported in about 60 percent of patients with diffuse goiter, hypothyroidism, or both, and antithyroid microsomal antibodies in 95 percent.64 The titers tend to be higher in patients with the atrophic form of autoimmune thyroiditis than in those with the goitrous form.

Most laboratories test for antithyroid microsomal antibodies by hemagglutination or test for anti–thyroid peroxidase antibodies by enzyme-linked immunoassay or radioimmunoassay. A positive test for anti–thyroid peroxidase antibodies is a slightly more sensitive indicator of chronic autoimmune thyroiditis than a positive test for antithyroid microsomal antibodies.63 However, since low titers of antithyroid antibodies may be present in patients with other thyroid diseases, tests for anti–thyroid peroxidase antibodies offer little advantage over tests for antithyroid microsomal antibodies in routine clinical practice. The higher prevalence and higher titers of both types of antibodies, as compared with antithyroglobulin antibodies, make measurements of the latter superfluous.80

In community surveys, 50 to 75 percent of subjects with positive tests for thyroid antibodies are euthyroid, but 25 to 50 percent have subclinical hypothyroidism and 5 to 10 percent have overt hypothyroidism. Some patients with chronic autoimmune thyroiditis may also have an elevated erythrocyte sedimentation rate, polyclonal hypergammaglobulinemia, monoclonal gammopathy, or antinuclear antibodies.

Radionuclide Imaging and Ultrasonography

Thyroid imaging is unnecessary in patients suspected of having goitrous autoimmune thyroiditis. Sometimes, however, the diagnosis is not suspected, and imaging is performed as part of an investigation of goiter. The radionuclide scan can be very misleading in such cases, because the pattern of uptake may mimic that of Graves' disease, multinodular goiter, or even a hyperfunctioning or hypofunctioning nodule.81 The uptake of radionuclide is characteristically normal or elevated in patients with goitrous autoimmune thyroiditis, even in the presence of hypothyroidism, whereas in those with subacute or silent thyroiditis, the uptake is low. Ultrasonography shows an enlarged thyroid gland with a diffusely hypoechogenic pattern in 18 to 77 percent of patients,77,78 but the findings are not specific.

Biopsy

The clinician should not be sidetracked by the presence of thyroid autoantibodies in a patient who has a suspicious nodule or a rapidly enlarging goiter; a fine-needle aspiration biopsy or large-needle biopsy is necessary. Fine-needle aspiration should be reserved for clinically suspicious areas, because oxyphil cells showing atypia may be misinterpreted as a follicular neoplasm, leading to unnecessary surgery (Figure 3Figure 3Specimen of Thyroid Obtained by Fine-Needle Aspiration Biopsy in a Patient with Chronic Autoimmune Thyroiditis, Showing a Clump of Oxyphilic Thyroid Follicular Cells Surrounded by Lymphocytes (Papanicolaou's Stain, ×600). (Courtesy of Dr. Wanda Szyfelbein.)).82,83 The diagnosis of high-grade lymphoma poses little difficulty. Lower grades of lymphoma may be suspected on the basis of the presence of monomorphic lymphocytes and appropriate immunohistochemical studies, in which case a biopsy with a larger-core needle or even an open biopsy is indicated for confirmation.84

Natural History

Progression of Subclinical Disease

In patients with chronic autoimmune thyroiditis, subclinical hypothyroidism can develop into overt hypothyroidism, but the progression is often extremely slow. In a 20-year follow-up study of the Whickham cohort, clinical or biochemical hypothyroidism developed in 55 percent of the women who initially had both positive tests for thyroid antibodies and elevated serum thyrotropin values (>6 mU per liter) but normal serum thyroxine values — a rate of progression of 4.3 percent per year.72 Among the women who initially had either a raised serum thyrotropin value or thyroid antibodies (but not both), only one had overt hypothyroidism after 4 years,85 but the 20-year rates of progression were 2.6 percent per year among the subjects with elevated serum thyrotropin values and 2.1 percent per year among those with antithyroid antibodies, resulting in rates of overt hypothyroidism of 33 and 27 percent, respectively, at the end of the follow-up period. The risk of a progression to overt hypothyroidism was five times higher among the men than among the women and increased markedly with age in women who were 45 years old or older. Higher initial serum thyrotropin concentrations predicted higher rates of progression (Figure 4Figure 4Probability of the Development of Overt Hypothyroidism in Women within 20 Years after the Initial Measurement of the Serum Thyrotropin Concentration.), as did higher initial titers of thyroid antibodies. These findings are consistent with the results of several smaller, shorter-term follow-up studies.68,86-88 Among patients with serum thyrotropin values higher than 20 mU per liter or titers of antithyroid microsomal antibodies higher than 1:100,000, overt hypothyroidism develops in 25 percent per year.87,89 Serum thyrotropin values that are only mildly elevated may return to normal, and subsequent tests for thyroid autoantibodies become negative in about 10 percent of patients.72

Graves' Disease and Chronic Autoimmune Thyroiditis

Graves' hyperthyroidism occasionally develops in patients with hypothyroidism caused by chronic autoimmune thyroiditis,90 confirming the fact that the latter condition does not always result in irreversible destruction of the thyroid. In contrast, among patients with Graves' hyperthyroidism who remain euthyroid after treatment with antithyroid agents or a partial thyroidectomy, hypothyroidism, presumably due to chronic autoimmune thyroiditis, develops in about 10 to 20 percent after 10 to 25 years.91-93

Thyroid Lymphoma

Thyroid lymphoma is a very rare but serious complication of chronic autoimmune thyroiditis. Among 5592 Japanese women with chronic autoimmune thyroiditis who were followed for an average of eight years, thyroid lymphoma developed in 0.1 percent, a prevalence 80 times higher than expected.94 Eighty to 100 percent of patients with thyroid lymphoma have evidence of chronic autoimmune thyroiditis in the surrounding tissue, and 67 to 80 percent have thyroid antibodies.95-98 The lymphomas are usually the non-Hodgkin's B-cell type, tend to occur in older women (50 to 80 years old), and are usually confined to the thyroid gland.95,97 Radiotherapy alone or combined with chemotherapy results in survival rates ranging from 13 to 92 percent at five years. Patients over 65 years old with large, rapidly growing tumors of histologically high grade have the worst prognosis.97,99

Chronic Autoimmune Thyroiditis and Pregnancy

Subclinical hypothyroidism has been associated with reduced fertility. The presence of thyroid antibodies alone does not affect the conception rate but has been associated with a rate of spontaneous abortion that is twice the normal rate100 and tends to be more common in women with recurrent spontaneous abortions.101 These findings are thought to represent a general tendency toward the development of autoimmunity rather than a toxic effect of thyroid antibodies. About 5 percent of infants whose mothers have chronic autoimmune thyroiditis (predominantly the atrophic form) have transient neonatal hypothyroidism, which is caused by transplacental passage of thyrotropin-receptor–blocking antibodies.102

The most common complication of chronic autoimmune thyroiditis in pregnant women is postpartum thyroiditis. This condition, which usually occurs two to six months after delivery, is characterized clinically by hyperthyroidism with a low 24-hour radioiodine uptake, by hypothyroidism, or by hyperthyroidism followed by hypothyroidism. The condition resolves spontaneously within a year.103 In areas with sufficient iodine, postpartum thyroiditis occurs in 35 to 85 percent of women who have positive tests for thyroid antibodies during pregnancy or in the postpartum period, as compared with 4 to 9 percent of pregnant women overall.104-106 Despite an initial recovery, about 25 percent of women have overt hypothyroidism four or more years later.107,108

Therapy

Hypothyroidism

All patients with overt hypothyroidism should be treated with thyroxine, and the dose should be adjusted to normalize the serum thyrotropin concentration. In elderly patients, particularly those with long-standing symptoms of hypothyroidism or coexistent ischemic heart disease, treatment should begin with a low dose (12.5 to 25 μg daily), with increments at intervals of four to six weeks, so that the serum thyrotropin concentration reaches a steady-state value after each change in the dose. In most women, a 25 to 50 percent increase in the dose is required during pregnancy to maintain normal serum thyrotropin concentrations.

The role of thyroxine therapy in patients with subclinical hypothyroidism is more controversial.109 In two placebo-controlled trials of thyroxine therapy in patients with subclinical hypothyroidism, symptom scores improved. In one of these studies, however, the majority of patients had treated hyperthyroidism (and serum thyrotropin concentrations up to 39 mU per liter) rather than chronic autoimmune thyroiditis,110 and in the other study, a fixed dose of thyroxine was given rather than titration of the dose to normalize the serum thyrotropin concentration.111 We recommend treatment if a patient has any symptoms potentially attributable to hypothyroidism, the serum thyrotropin concentration is higher than 10 mU per liter, the patient is at high risk for progression to overt hypothyroidism (because of a strongly positive test for thyroid autoantibodies, an age over 45 years, or male sex), and heart disease is absent. If surveillance rather than treatment is planned, the serum thyrotropin concentration should be measured in six months and subsequently every one to two years.

Up to 24 percent of patients with hypothyroidism caused by chronic autoimmune thyroiditis who are treated with thyroxine for more than one year remain euthyroid when the drug is withdrawn.33,112,113 Such a remission may result from the disappearance of thyrotropin-receptor–blocking antibodies33 (see above) or the cessation of treatment with cytokines, lithium, amiodarone, or other iodine-containing substances. Remission can be established only by reducing the dose of thyroxine or withdrawing the drug. Testing for remission should be performed if the diagnosis was made within a year after parturition or if the patient was eating foods very high or low in iodine or receiving relevant drug or cytokine therapy. In the majority of hypothyroid patients with positive thyroid-antibody tests, however, testing for remission by discontinuing thyroxine therapy is justified only if requested by the patient. Self-limited hypothyroidism may also be caused by undiagnosed silent, postpartum, or viral thyroiditis.

Goiter

Thyroxine may also be given to decrease the size of the goiter in euthyroid patients with goitrous autoimmune thyroiditis. In 50 to 90 percent of patients, the size of the goiter decreases by an average of 30 percent after treatment with thyroxine for six months, irrespective of the initial serum thyrotropin concentration.9,114,115 Thyroid-antibody titers may also decline during therapy, and thyroid tenderness, if present, may be relieved.116,117

Associations with Other Diseases

Although chronic autoimmune thyroiditis is common in the general population, the prevalence rate is higher in patients with multiple endocrine neoplasia type II (70 percent), the POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes) (50 percent), Turner's syndrome (50 percent), Addison's disease (20 percent), and Down's syndrome (20 percent), as well as other diseases. Serum thyrotropin concentrations should be measured periodically in patients with these disorders.

Conclusions

Chronic autoimmune thyroiditis is the most common and extensively studied organ-specific autoimmune disorder in humans. The ability to detect thyroid enlargement clinically and the availability of very sensitive tests for thyroid antibodies and thyrotropin have revealed many previously unrecognized cases of subclinical disease. As in the initial cases described by Hashimoto, permanent hypothyroidism is not inevitable. Progressive disease appears to be signaled by a high titer of thyroid antibodies and elevated serum thyrotropin concentrations, especially in patients over the age of 45 years and in association with thyroid atrophy. The underlying mechanisms responsible for initiating thyroid autoimmunity and promoting the progression of the disease remain unknown.

Source Information

From the University Department of Medicine, Bristol Royal Infirmary, Bristol, United Kingdom (C.M.D.), and the Thyroid Unit, Massachusetts General Hospital, Boston (G.H.D.).

Address reprint requests to Dr. Daniels at the Thyroid Unit, ACC730, Massachusetts General Hospital, Boston, MA 02114.

References

References

1. 1

   Hashimoto H. Zur Kenntniss der lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa). Arch Klin Chir 1912;97:219-248
   

2. 2

   Roitt IM, Doniach D, Campbell PN, Hudson RV. Auto-antibodies in Hashimoto's disease (lymphadenoid goitre). Lancet 1956;2:820-821
   CrossRef

3. 3

   Nagataki S. The concept of Hashimoto disease. In: Nagataki S, Mori T, Torizuka K, eds. 80 Years of Hashimoto disease. Amsterdam: Elsevier Science, 1993:539-45.
   

4. 4

   Costa A, Torchio B, Zoppetti G, Feyless E. What is meant today by Hashimoto's thyroiditis? J Endocrinol Invest 1989;12:355-356
   Web of Science | Medline

5. 5

   Volpé R. Autoimmune thyroiditis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid: a fundamental and clinical text. 6th ed. Philadelphia: J.B. Lippincott, 1991:921-33.
   

6. 6

   Hay ID. Thyroiditis: a clinical update. Mayo Clin Proc 1985;60:836-843
   Web of Science | Medline

7. 7

   Livolsi VA. The pathology of autoimmune thyroid disease: a review. Thyroid 1994;4:333-339
   CrossRef | Web of Science | Medline

8. 8

   Vickery AL, Hamblin E Jr. Struma lymphomatosa (Hashimoto's thyroiditis): observations on repeated biopsies in sixteen patients. N Engl J Med 1961;264:226-229
   Full Text | Web of Science | Medline

9. 9

   Hayashi Y, Tamai H, Fukata S, et al. A long term clinical, immunological, and histological follow-up study of patients with goitrous chronic lymphocytic thyroiditis. J Clin Endocrinol Metab 1985;61:1172-1178
   CrossRef | Web of Science | Medline

10. 10

    Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 1994;15:788-830
    Web of Science | Medline

11. 11

    Dayan CM, Londei M, Corcoran AE, et al. Autoantigen recognition by thyroid-infiltrating T cells in Graves' disease. Proc Natl Acad Sci U S A 1991;88:7415-7419
    CrossRef | Web of Science | Medline

12. 12

    Davies TF, Martin A, Concepcion ES, Graves P, Cohen L, Ben-Nun A. Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. N Engl J Med 1991;325:238-244
    Free Full Text | Web of Science | Medline

13. 13

    McIntosh RS, Tandon N, Pickerill AP, Davies R, Barnett D, Weetman AP. IL-2 receptor-positive intrathyroidal lymphocytes in Graves' disease: analysis of V alpha transcript microheterogeneity. J Immunol 1993;151:3884-3893
    Web of Science | Medline

14. 14

    Valtonen VV, Ruutu P, Varis K, Ranki M, Malkamaki M, Makela PH. Serological evidence for the role of bacterial infections in the pathogenesis of thyroid diseases. Acta Med Scand 1986;219:105-111
    CrossRef | Web of Science | Medline

15. 15

    Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity. Endocr Rev 1993;14:107-120
    Web of Science | Medline

16. 16

    Drabick JJ, Horning VL, Lennox JL, et al. A retrospective analysis of diseases associated with indeterminate HIV Western blot patterns. Mil Med 1991;156:93-96
    Web of Science | Medline

17. 17

    Volpe R. A perspective on human autoimmune thyroid disease: is there an abnormality of the target cell which predisposes to the disorder? Autoimmunity 1992;13:3-9
    CrossRef | Web of Science | Medline

18. 18

    Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RCG, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 1983;2:1111-1115
    CrossRef | Web of Science | Medline

19. 19

    Todd I, Pujol-Borrell R, Hammond LJ, Bottazzo GF, Feldman M. Interferon-gamma induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol 1985;61:265-273
    Web of Science | Medline

20. 20

    Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983;2:1115-1119
    CrossRef | Web of Science | Medline

21. 21

    Londei M, Bottazzo GF, Feldmann M. Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science 1985;228:85-89
    CrossRef | Web of Science | Medline

22. 22

    Tandon N, Metcalfe RA, Barnett D, Weetman AP. Expression of the costimulatory molecule B7/BB1 in autoimmune thyroid disease. Q J Med 1994;87:231-236
    Web of Science | Medline

23. 23

    Czarnocka B, Ruf J, Ferrand M, Carayon P, Lissitzky S. Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid disease. FEBS Lett 1985;190:147-152
    CrossRef | Web of Science | Medline

24. 24

    Dumont JE, Roger PP, Ludgate M. Assays for thyroid growth immunoglobulins and their clinical implications: methods, concepts and misconceptions. Endocr Rev 1987;8:448-452
    CrossRef | Web of Science | Medline

25. 25

    Del Prete GF, Vercelli D, Tiri A, et al. In vivo activated cytotoxic T cells in the thyroid infiltrate of patients with Hashimoto's thyroiditis. Clin Exp Immunol 1986;65:140-147
    Web of Science | Medline

26. 26

    Kohno Y, Yamaguchi F, Saito K, Niimi H, Nishikawa T, Hosoya T. Anti-thyroid peroxidase antibodies in sera from healthy subjects and from patients with chronic thyroiditis: differences in the ability to inhibit thyroid peroxidase activities. Clin Exp Immunol 1991;85:459-463
    CrossRef | Web of Science | Medline

27. 27

    Khoury EL, Hammond L, Bottazzo GF, Doniach D. Presence of the organ-specific `microsomal' autoantigen on the surface of human thyroid cells in culture: its involvement in complement-mediated cytotoxicity. Clin Exp Immunol 1981;45:316-328
    Web of Science | Medline

28. 28

    Bogner U, Kotulla P, Peters H, Schleusener H. Thyroid peroxidase/microsomal antibodies are not identical with thyroid cytotoxic antibodies in autoimmune thyroiditis. Acta Endocrinol Suppl (Copenh) 1990;123:431-437
    

29. 29

    Chiovato L, Bassi P, Santini F, et al. Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 1993;77:1700-1705
    CrossRef | Web of Science | Medline

30. 30

    Weetman AP, Cohen SB, Oleesky DA, Morgan BP. Terminal complement complexes and C1/C1 inhibitor complexes in autoimmune thyroid disease. Clin Exp Immunol 1989;77:25-30
    Web of Science | Medline

31. 31

    Konishi J, Kasagi K, Iida Y. Thyroid stimulation blocking antibodies — an overview. In: Nagataki S, Mori T, Torizuka K, eds. 80 Years of Hashimoto disease. Amsterdam: Elsevier Science, 1993:573-7.
    

32. 32

    Tamaki H, Amino N, Kimura M, Hidaka Y, Takeoka K, Miyai K. Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan. J Clin Endocrinol Metab 1990;71:1382-1386
    CrossRef | Web of Science | Medline

33. 33

    Takasu N, Yamada T, Takasu M, et al. Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. N Engl J Med 1992;326:513-518
    Free Full Text | Web of Science | Medline

34. 34

    Phillips D, McLachlan S, Stephenson A, et al. Autosomal dominant transmission of autoantibodies to thyroglobulin and thyroid peroxidase. J Clin Endocrinol Metab 1990;70:742-746
    CrossRef | Web of Science | Medline

35. 35

    Phillips D, Prentice L, Upadhyaya M, et al. Autosomal dominant inheritance of autoantibodies to thyroid peroxidase and thyroglobulin -- studies in families not selected for autoimmune thyroid disease. J Clin Endocrinol Metab 1991;72:973-975
    CrossRef | Web of Science | Medline

36. 36

    Roitt IM, Doniach D. A reassessment of studies on the aggregation of thyroid autoimmunity in families of thyroiditis patients. Clin Exp Immunol 1967;2:Suppl:727-736
    Medline

37. 37

    Chopra IJ, Solomon DH, Chopra U, Yoshihara E, Terasaki PI, Smith F. Abnormalities in thyroid function in relatives of patients with Graves' disease and Hashimoto's thyroiditis: lack of correlation with inheritance of HLA-B8. J Clin Endocrinol Metab 1977;45:45-54
    CrossRef | Web of Science | Medline

38. 38

    Honda K, Tamai J, Morita T, Kuma K, Nishimura Y, Sasazuki T. Hashimoto's thyroiditis and HLA in Japanese. J Clin Endocrinol Metab 1989;69:1268-1273
    CrossRef | Web of Science | Medline

39. 39

    Tamai H, Kimura A, Dong R-P, et al. Resistance to autoimmune thyroid disease is associated with HLA-DQ. J Clin Endocrinol Metab 1994;78:94-97
    CrossRef | Web of Science | Medline

40. 40

    Roman SH, Greenberg D, Rubinstein P, Wallenstein S, Davies TF. Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. J Clin Endocrinol Metab 1992;74:496-503
    CrossRef | Web of Science | Medline

41. 41

    Kennedy RL, Jones TH, Cuckle HS. Down's syndrome and the thyroid. Clin Endocrinol (Oxf) 1992;37:471-476
    CrossRef | Web of Science | Medline

42. 42

    Ewins DL, Rossor MN, Butler J, Roques PK, Mullan MJ, McGregor AM. Association between autoimmune thyroid disease and familial Alzheimer's disease. Clin Endocrinol (Oxf) 1991;35:93-96
    CrossRef | Web of Science | Medline

43. 43

    de Kerdanet M, Lucas J, Lemee F, Lecornu M. Turner's syndrome with X-isochromosome and Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 1994;41:673-676
    CrossRef | Web of Science | Medline

44. 44

    Laurberg P. Iodine intake -- what are we aiming at? J Clin Endocrinol Metab 1994;79:17-19
    CrossRef | Web of Science | Medline

45. 45

    Harach HR, Escalante DA, Onativia A, Outes JL, Day ES, Williams ED. Thyroid carcinoma and thyroiditis in an endemic goitre region before and after iodine prophylaxis. Acta Endocrinol (Copenh) 1985;108:55-60
    Medline

46. 46

    Boukis MA, Koutras DA, Souvatzoglou A, Evangelopoulou A, Vrontakis M, Moulopoulos SD. Thyroid hormone and immunological studies in endemic goiter. J Clin Endocrinol Metab 1983;57:859-862
    CrossRef | Web of Science | Medline

47. 47

    Chow CC, Phillips DI, Lazarus JH, Parkes AB. Effect of low dose iodide supplementation on thyroid function in potentially susceptible subjects: are dietary iodide levels in Britain acceptable? Clin Endocrinol (Oxf) 1991;34:413-416
    CrossRef | Web of Science | Medline

48. 48

    Konno N, Makita H, Yuri K, Iizuka N, Kawasaki K. Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J Clin Endocrinol Metab 1994;78:393-397
    CrossRef | Web of Science | Medline

49. 49

    Braverman LE, Ingbar SH, Vagenakis AG, Adams L, Maloof F. Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease. J Clin Endocrinol Metab 1971;32:515-521
    CrossRef | Web of Science | Medline

50. 50

    Trip MD, Wiersinga W, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med 1991;91:507-511
    CrossRef | Web of Science | Medline

51. 51

    Emerson CH, Dysno WL, Utiger RD. Serum thyrotropin and thyroxine concentrations in patients receiving lithium carbonate. J Clin Endocrinol Metab 1973;36:338-346
    CrossRef | Web of Science | Medline

52. 52

    Lazarus JH, John R, Bennie EH, Chalmers RJ, Crockett G. Lithium therapy and thyroid function: a long-term study. Psychol Med 1981;11:85-92
    CrossRef | Web of Science | Medline

53. 53

    Burman P, Totterman TH, Oberg K, Karlsson FA. Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon. J Clin Endocrinol Metab 1986;63:1086-1090
    CrossRef | Web of Science | Medline

54. 54

    Sauter NP, Atkins MB, Mier JW, Lechan RM. Transient thyrotoxicosis and persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2 and interferon-alpha therapy for metastatic carcinoma: a case report. Am J Med 1992;92:441-444
    CrossRef | Web of Science | Medline

55. 55

    Gisslinger H, Gilly B, Woloszczuk W, et al. Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin Exp Immunol 1992;90:363-367
    CrossRef | Web of Science | Medline

56. 56

    Imagawa A, Itoh N, Hanafusa T, et al. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis. J Clin Endocrinol Metab 1995;80:922-926
    CrossRef | Web of Science | Medline

57. 57

    Atkins MB, Mier JW, Parkinson DR, Gould JA, Berkman EM, Kaplan MM. Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med 1988;318:1557-1563
    Full Text | Web of Science | Medline

58. 58

    Hoekman K, von Blomberg-van der Flier BME, Wagstaff J, Drexhage HA, Pinedo HM. Reversible thyroid dysfunction during treatment with GM-CSF. Lancet 1991;338:541-542
    CrossRef | Web of Science | Medline

59. 59

    Watanabe U, Hashimoto E, Hisamitsu T, Obata H, Hayashi N. The risk factors for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C. Am J Gastroenterol 1994;89:399-403
    Web of Science | Medline

60. 60

    Bhakri H, Sriskandan K, Davis T, Pettingale K, Tee D. Recombinant gamma interferon and autoimmune thyroid disease. Lancet 1985;2:457-457
    CrossRef | Web of Science | Medline

61. 61

    Williams ED, Doniach I. The post-mortem incidence of focal thyroiditis. J Pathol Bacteriol 1962;83:255-264
    CrossRef | Web of Science | Medline

62. 62

    Okayasu I, Hara Y, Nakamura K, Rose NR. Racial and age-related differences in incidence and severity of focal autoimmune thyroiditis. Am J Clin Pathol 1994;101:698-702
    Web of Science | Medline

63. 63

    Mariotti S, Caturegli P, Piccolo P, Barbesino G, Pinchera A. Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab 1990;71:661-669
    CrossRef | Web of Science | Medline

64. 64

    Amino N, Hagen SR, Yamada N, Refetoff S. Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid diseases. Clin Endocrinol (Oxf) 1976;5:115-125
    CrossRef | Web of Science | Medline

65. 65

    Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977;7:481-493
    CrossRef | Web of Science | Medline

66. 66

    Barbato MP. Thyroid autoantibodies in an Australian community. Med J Aust 1978;2:511-512
    Web of Science | Medline

67. 67

    Mariotti S, Sansoni P, Barbesino G, et al. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet 1992;339:1506-1508
    CrossRef | Web of Science | Medline

68. 68

    Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 1991;34:77-83
    CrossRef | Web of Science | Medline

69. 69

    Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age 55 years: a study in an urban US community. Arch Intern Med 1990;150:785-787
    CrossRef | Web of Science | Medline

70. 70

    Ladenson PW, Wilson WC, Gardin J, et al. Relationship of subclinical hypothyroidism to cardiovascular risk factors and disease in an elderly population. Thyroid 1994;4:Suppl 1:S-18 abstract.
    

71. 71

    Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid: thyroid deficiency in the Framingham Study. Arch Intern Med 1985;145:1386-1388
    CrossRef | Web of Science | Medline

72. 72

    Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995;43:55-68
    CrossRef | Web of Science | Medline

73. 73

    Doniach D, Bottazzo GF, Russell RCG. Goitrous autoimmune thyroiditis (Hashimoto's disease). Clin Endocrinol Metab 1979;8:63-80
    CrossRef | Medline

74. 74

    Tsuboi K, Yuasa R, Tanaka Y, Ueshiba H, Takeda S, Ito K. Incidence of thyroid atrophy in patients with Hashimoto thyroiditis. In: Nagataki S, Mori T, Torizuka K, eds. 80 Years of Hashimoto disease. Amsterdam: Elsevier Science, 1993:69-72.
    

75. 75

    Rallison ML, Dobyns BM, Meikle AW, Bishop M, Lyon JL, Stevens W. Natural history of thyroid abnormalities: prevalence, incidence, and regression of thyroid diseases in adolescents and young adults. Am J Med 1991;91:363-370[Erratum, J Med 1992;92:582.]
    CrossRef | Web of Science | Medline

76. 76

    Katz SM, Vickery AL Jr. The fibrous variant of Hashimoto's thyroiditis. Hum Pathol 1974;5:161-170
    CrossRef | Web of Science | Medline

77. 77

    Sostre S, Reyes MM. Sonographic diagnosis and grading of Hashimoto's thyroiditis. J Endocrinol Invest 1991;14:115-121
    Web of Science | Medline

78. 78

    Nordmeyer JP, Shafeh TA, Heckmann C. Thyroid sonography in autoimmune thyroiditis: a prospective study on 123 patients. Acta Endocrinol (Copenh) 1990;122:391-395
    Medline

79. 79

    Zimmerman RS, Brennan MD, McConahey WM, Goellner JR, Gharib H. Hashimoto's thyroiditis: an uncommon cause of painful thyroid unresponsive to corticosteroid therapy. Ann Intern Med 1986;104:355-357
    Web of Science | Medline

80. 80

    Nordyke RA, Gilbert FI Jr, Miyamoto LA, Fleury KA. The superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimoto's thyroiditis. Arch Intern Med 1993;153:862-865
    CrossRef | Web of Science | Medline

81. 81

    Ramtoola S, Maisey MN, Clark SEM, Fogelman I. The thyroid scan in Hashimoto's thyroiditis: the great mimic. Nucl Med Commun 1988;9:639-645
    CrossRef | Web of Science | Medline

82. 82

    Hypothyroidism and enlarging thyroid mass in a young womanAm J Med 1993;95:534-541
    CrossRef | Web of Science | Medline

83. 83

    Ravinsky E, Safneck JR. Differentiation of Hashimoto's thyroiditis from thyroid neoplasms in fine needle aspirates. Acta Cytol 1988;32:854-861
    Web of Science | Medline

84. 84

    Tani E, Skoog L. Fine needle aspiration cytology and immunocytochemistry in the diagnosis of lymphoid lesions of the thyroid gland. Acta Cytol 1989;33:48-52
    Web of Science | Medline

85. 85

    Tunbridge WMG, Brewis M, French JM, et al. Natural history of autoimmune thyroiditis. BMJ 1981;282:258-262
    CrossRef | Web of Science | Medline

86. 86

    Geul KW, van Sluisveld ILL, Grobbee DE, et al. The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women: associations with serum lipids. Clin Endocrinol (Oxf) 1993;39:275-280
    CrossRef | Web of Science | Medline

87. 87

    Rosenthal MJ, Hunt WC, Garry PJ, Goodwin JS. Thyroid failure in the elderly: microsomal antibodies as discriminant for therapy. JAMA 1987;258:209-213
    CrossRef | Web of Science | Medline

88. 88

    Lazarus JH, Burr ML, McGregor AM, et al. The prevalence and progression of autoimmune thyroid disease in the elderly. Acta Endocrinol (Copenh) 1984;106:199-202
    Medline

89. 89

    Gordin A, Lamberg B-A. Spontaneous hypothyroidism in symptomless autoimmune thyroiditis: a long-term follow-up study. Clin Endocrinol (Oxf) 1981;15:537-543
    CrossRef | Web of Science | Medline

90. 90

    Kurihara H, Sasaki J, Takamatsu M. Twenty cases with Hashimoto disease changing to Graves' disease. In: Nagataki S, Mori T, Torizuka K, eds. 80 Years of Hashimoto disease. Amsterdam: Elsevier Science, 1993:249-53.
    

91. 91

    Sugrue D, McEvoy M, Feely J, Drury MI. Hyperthyroidism in the land of Graves: results of treatment by surgery, radio-iodine and carbimazole in 837 cases. Q J Med 1980;49:51-61
    Web of Science | Medline

92. 92

    Wood LC, Ingbar SH. Hypothyroidism as a late sequela in patients with Graves' disease treated with antithyroid agents. J Clin Invest 1979;64:1429-1436
    CrossRef | Web of Science | Medline

93. 93

    Hedley AJ, Young RE, Jones SJ, Alexander WD, Bewsher PD. Antithyroid drugs in the treatment of hyperthyroidism of Graves' disease:long-term follow-up of 434 patients. Clin Endocrinol (Oxf) 1989;31:209-218
    CrossRef | Web of Science | Medline

94. 94

    Kato I, Tajima K, Suchi T, et al. Chronic thyroiditis as a risk factor for B-cell lymphoma in the thyroid gland. Jpn J Cancer Res 1985;76:1085-1090
    Medline

95. 95

    Matsuzuka F, Miyauchi A, Katayama S, et al. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid 1993;3:93-99
    CrossRef | Web of Science | Medline

96. 96

    Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985;312:601-604
    Full Text | Web of Science | Medline

97. 97

    Aozasa K, Inoue A, Tajima K, Miyauchi A, Matsuzuka F, Kuma K. Malignant lymphomas of the thyroid gland: analysis of 79 patients with emphasis on histologic prognostic factors. Cancer 1986;58:100-104
    CrossRef | Web of Science | Medline

98. 98

    Maurer R, Taylor CR, Terry R, Lukes RJ. Non-Hodgkin lymphomas of the thyroid: a clinico-pathological review of 29 cases applying the Luke-Collins classification and an immunoperoxidase method. Virchows Arch A Pathol Anat Histol 1979;383:293-317
    CrossRef | Web of Science | Medline

99. 99

    Oertel JE, Heffess CS. Lymphoma of the thyroid and related disorders. Semin Oncol 1987;14:333-342
    Web of Science | Medline

100. 100

     Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Alvarez-Marfany M, Davies TF. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990;264:1422-1425
     CrossRef | Web of Science | Medline

101. 101

     Pratt D, Novotny M, Kaberlein G, Dudkiewicz A, Gleicher N. Antithyroid antibodies and the association with non-organ specific antibodies in recurrent pregnancy loss. Am J Obstet Gynecol 1993;168:837-841
     Web of Science | Medline

102. 102

     Tamaki H, Amino N, Aozasa M, et al. Effective method for prediction of transient hypothyroidism in neonates born to mothers with chronic thyroiditis. Am J Perinatol 1989;6:296-303
     CrossRef | Web of Science | Medline

103. 103

     Stagnaro-Green A. Postpartum thyroiditis: prevalence, etiology and clinical implications. Thyroid Today 1993;16:1-11
     

104. 104

     Vargas MT, Briones-Urbina R, Gladman D, Papsin FR, Walfish PG. Antithyroid microsomal autoantibodies and HLA-DR5 are associated with postpartum thyroid dysfunction: evidence supporting an autoimmune pathogenesis. J Clin Endocrinol Metab 1988;67:327-333
     CrossRef | Web of Science | Medline

105. 105

     Hayslip CC, Fein HG, O'Donnell VM, Friedman DS, Klein TA, Smallridge RC. The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction. Am J Obstet Gynecol 1988;159:203-209
     Web of Science | Medline

106. 106

     Gerstein HC. How common is postpartum thyroiditis? A methodologic overview of the literature. Arch Intern Med 1990;150:1397-1400
     CrossRef | Web of Science | Medline

107. 107

     Othman S, Phillips DIW, Parkes AB, et al. A long-term follow-up of postpartum thyroiditis. Clin Endocrinol (Oxf) 1990;32:559-564
     CrossRef | Web of Science | Medline

108. 108

     Tachi J, Amino N, Tamaki H, Aozasa M, Iwatani Y, Miyai K. Long term follow-up and HLA association in patients with postpartum hypothyroidism. J Clin Endocrinol Metab 1988;66:480-484
     CrossRef | Web of Science | Medline

109. 109

     Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy in patients with thyroid disease. Ann Intern Med 1993;119:492-502
     Web of Science | Medline

110. 110

     Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med 1984;101:18-24
     Web of Science | Medline

111. 111

     Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg P-A, Lindstedt G. A double-blind cross-over 12-month study of L-thyroxine treatment of women with “subclinical“ hypothyroidism. Clin Endocrinol (Oxf) 1988;29:63-75
     CrossRef | Web of Science | Medline

112. 112

     Takasu N, Komiya I, Asawa T, Nagasawa Y, Yamada T. Test for recovery from hypothyroidism during thyroxine therapy in Hashimoto's thyroiditis. Lancet 1990;336:1084-1086
     CrossRef | Web of Science | Medline

113. 113

     Utiger RD. Vanishing hypothyroidism. N Engl J Med 1992;326:562-563
     Full Text | Web of Science | Medline

114. 114

     Hegedus L, Hansen JM, Feldt-Rasmussen U, Hansen BM, Hoier-Madsen M. Influence of thyroxine treatment on thyroid size and anti-thyroid peroxidase antibodies in Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 1991;35:235-238
     CrossRef | Web of Science | Medline

115. 115

     Kikuchi T, Yamaguchi Y, Kobayashi T, et al. Studies on thyroid volume during thyroid hormone therapy in patients with Hashimoto thyroiditis. In: Nagataki S, Mori T, Torizuka K, eds. 80 Years of Hashimoto disease. Amsterdam: Elsevier Science, 1993:201-3.
     

116. 116

     Chiovato L, Marcocci C, Mariotti S, Mori A, Pinchera A. L-thyroxine therapy induces a fall of thyroid microsomal and thyroglobulin antibodies in idiopathic myxedema and in hypothyroid, but not in euthyroid Hashimoto's thyroiditis. J Endocrinol Invest 1986;9:299-305
     Web of Science | Medline

117. 117

     Rieu M, Richard A, Rosilio M, et al. Effects of thyroid status on thyroid autoimmunity expression in euthyroid and hypothyroid patients with Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 1994;40:529-535
     CrossRef | Web of Science | Medline

Citing Articles (196)

Citing Articles

1. 1

   Kai-Ming Wu, Yi-Ping Wang, Hung-Pin Lin, Hsin-Ming Chen, Jean-San Chia, Andy Sun. (2013) Modulation of serum smooth muscle antibody levels by levamisole treatment in patients with oral lichen planus. Journal of the Formosan Medical Association 112:6, 352-357
   

2. 2

   Jolanda M. Denham, Ivor D. Hill. (2013) Celiac Disease and Autoimmunity: Review and Controversies. Current Allergy and Asthma Reports
   

3. 3

   Danilo B. Höfling, Maria Cristina Chavantes, Adriana G. Juliano, Giovanni G. Cerri, Meyer Knobel, Elisabeth M. Yoshimura, Maria Cristina Chammas. (2013) Low-level laser in the treatment of patients with hypothyroidism induced by chronic autoimmune thyroiditis: a randomized, placebo-controlled clinical trial. Lasers in Medical Science 28:3, 743-753
   

4. 4

   Saeko Hoshikawa, Yoshinori Nakagawa, Hiroshi Ozaki, Yurie Takahashi, Sadayoshi Ito, Katsumi Yoshida, Kouki Mori. (2013) Effects of Green Tea Polyphenols on Iodide-Induced Autoimmune Thyroiditis In Nonobese Diabetic Mice. Immunological Investigations 42:3, 235-246
   

5. 5

   R. Rostami, M.R. Aghasi, A. Mohammadi, J. Nourooz-Zadeh. (2013) Enhanced oxidative stress in Hashimoto's thyroiditis: Inter-relationships to biomarkers of thyroid function. Clinical Biochemistry 46:4-5, 308-312
   

6. 6

   O. Kordonouri. (2013) Schilddrüsenerkrankungen und Zöliakie. Der Diabetologe 9:2, 128-134
   

7. 7

   C. Massart, M. d’Herbomez. (2013) Autoanticorps des maladies auto-immunes de la thyroïde. Indications des dosages. EMC - Biologie Médicale 8:1, 1-10
   

8. 8

   Silvia Garelli, Stefano Masiero, Mario Plebani, Shu Chen, Jadwiga Furmaniak, Decio Armanini, Corrado Betterle. (2013) High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology
   

9. 9

   Davide Brancato, Roberto Citarrella, Pierina Richiusa, Marco Calogero Amato, Calogero Vetro, Carla Giordano Galluzzo. (2013) Neck Lymph Nodes in Chronic Autoimmune Thyroiditis: The Sonographic Pattern. Thyroid 23:2, 173-177
   

10. 10

    A. Vrieze, P.F. de Groot, R.S. Kootte, M. Knaapen, E. van Nood, M. Nieuwdorp. (2013) Fecal transplant: A safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease?. Best Practice & Research Clinical Gastroenterology 27:1, 127-137
    

11. 11

    Sara Salehi Hammerstad, Frode Lars Jahnsen, Sisko Tauriainen, Heikki Hyöty, Trond Paulsen, Ingrid Norheim, Knut Dahl-Jørgensen. (2013) Inflammation and Increased Myxovirus Resistance Protein A Expression in Thyroid Tissue in the Early Stages of Hashimoto's Thyroiditis. Thyroid130111061523005
    

12. 12

    Clement E. Tagoe, Anna Zezon, Saakshi Khattri, Patricia Castellanos. (2013) Rheumatic manifestations of euthyroid, anti-thyroid antibody-positive patients. Rheumatology International
    

13. 13

    Carol F. Adair. Non-neoplastic lesions of the thyroid gland. In: Head and Neck Pathology. Elsevier, 2013:498-545.
    

14. 14

    Galina A. Legostaeva, Nataliya P. Zaksas, Yordanka G. Gluhcheva, Sergey E. Sedykh, Maria E. Madzharova, Nina N. Atanassova, Valentina N. Buneva, Georgy A. Nevinsky. (2013) Effect of CoCl ₂ on the content of different metals and a relative activity of DNA-hydrolyzing abzymes in the blood plasma of mice. Journal of Molecular Recognition 26:1, 10-22
    

15. 15

    Alessandra Dellavance, Eduardo Luiz R. Cançado, Clarice Pires Abrantes-Lemos, Michelle Harriz, Valdecir Marvulle, Luis Eduardo C. Andrade. (2012) Humoral autoimmune response heterogeneity in the spectrum of primary biliary cirrhosis. Hepatology International
    

16. 16

    Carolina Barragán-Martínez, Jenny Amaya-Amaya, Ricardo Pineda-Tamayo, Rubén D. Mantilla, Juan Castellanos-de la Hoz, Santiago Bernal-Macías, Adriana Rojas-Villarraga, Juan-Manuel Anaya. (2012) Gender Differences in Latin-American Patients With Rheumatoid Arthritis. Gender Medicine 9:6, 490-510.e5
    

17. 17

    C.-Y. Huang, T.-Y. Chang, C.-C. Chu, F.-S. Lo, W.-H. Ting, C.-H. Lin, Y.-L. Wu, S.-Y. Chu, S.-C. Chang, W.-F. Chen, C.-L. Lin, W.-S. Lin, Y.-J. Lee. (2012) The HLA-B gene and Hashimoto disease in Han Chinese children: a case-control and family-based study. Tissue Antigens 80:5, 431-436
    

18. 18

    Maria Angela Zaccarelli-Marino. (2012) Chronic Autoimmune Thyroiditis in Industrial Areas in Brazil: A 15-Year Survey. Journal of Clinical Immunology 32:5, 1012-1018
    

19. 19

    Stefano Mariotti. Chronic Autoimmune Thyroiditis. In: Thyroid Diseases. CRC Press, 2012:77-96.
    

20. 20

    Yi-Ping Wang, Hung-Pin Lin, Hsin-Ming Chen, Ying-Shiung Kuo, Ming-Jane Lang, Andy Sun. (2012) Hemoglobin, iron, and vitamin B12 deficiencies and high blood homocysteine levels in patients with anti-thyroid autoantibodies. Journal of the Formosan Medical Association
    

21. 21

    Karsten Müssig, Andreas Künle, Anna-Laura Säuberlich, Claudia Weinert, Thomas Ethofer, Ralf Saur, Reinhild Klein, Hans-Ulrich Häring, Stefan Klingberg, Baptist Gallwitz, Thomas Leyhe. (2012) Thyroid peroxidase antibody positivity is associated with symptomatic distress in patients with Hashimoto’s thyroiditis. Brain, Behavior, and Immunity 26:4, 559-563
    

22. 22

    Maria Papaleontiou, Megan R. Haymart. (2012) Approach to and Treatment of Thyroid Disorders in the Elderly. Medical Clinics of North America 96:2, 297-310
    

23. 23

    C. B. Filho, F. F. Rodrigues, L. Segat, A. M. Fonseca, J. Araujo, C. Arahata, L. Pontes, L. Vilar, J. L. de Lima Filho, S. Crovella. (2012) Association of MBL2 gene exon 1 variants with autoimmune thyroid disease in Brazilian patients. International Journal of Immunogeneticsno-no
    

24. 24

    Nikolaos Stathatos. (2012) Thyroid Physiology. Medical Clinics of North America
    

25. 25

    Mojtaba Mehrdad, Fariborz Mansour-Ghanaei, Fereshteh Mohammadi, Farahnaz Joukar, Salimeh Dodangeh, Roya Mansour-Ghanaei. (2012) Frequency of Celiac Disease in Patients with Hypothyroidism. Journal of Thyroid Research 2012, 1-6
    

26. 26

    Nikolaos Stathatos, Gilbert H. Daniels. (2012) Autoimmune thyroid disease. Current Opinion in Rheumatology 24:1, 70-75
    

27. 27

    Brian Casey. . 2012:178.
    

28. 28

    Jong Ryeal Hahm. (2012) Autoimmune Thyroid Diseases. Hanyang Medical Reviews 32:4, 219
    

29. 29

    Danilo Bianchini Höfling, Maria Cristina Chavantes, Adriana G. Juliano, Giovanni G. Cerri, Meyer Knobel, Elisabeth M. Yoshimura, Maria Cristina Chammas. (2012) Assessment of the Effects of Low-Level Laser Therapy on the Thyroid Vascularization of Patients with Autoimmune Hypothyroidism by Color Doppler Ultrasound. ISRN Endocrinology 2012, 1-9
    

30. 30

    Jorge Cárdenas Roldán, Jenny Amaya-Amaya, Juan Castellanos-de la Hoz, Juliana Giraldo-Villamil, Gladys Montoya-Ortiz, Paola Cruz-Tapias, Adriana Rojas-Villarraga, Rubén D. Mantilla, Juan-Manuel Anaya. (2012) Autoimmune Thyroid Disease in Rheumatoid Arthritis: A Global Perspective. Arthritis 2012, 1-15
    

31. 31

    Raman K Marwaha, Nikhil Tandon, M K Garg, Ratnesh Kanwar, A Sastry, A Narang, S Arora, Kuntal Bhadra. (2011) Thyroid status two decades after salt iodisation: Country-wide data in school children from India. Clinical Endocrinologyno-no
    

32. 32

    Joshua C. Denny, Dana C. Crawford, Marylyn D. Ritchie, Suzette J. Bielinski, Melissa A. Basford, Yuki Bradford, High Seng Chai, Lisa Bastarache, Rebecca Zuvich, Peggy Peissig, David Carrell, Andrea H. Ramirez, Jyotishman Pathak, Russell A. Wilke, Luke Rasmussen, Xiaoming Wang, Jennifer A. Pacheco, Abel N. Kho, M. Geoffrey Hayes, Noah Weston, Martha Matsumoto, Peter A. Kopp, Katherine M. Newton, Gail P. Jarvik, Rongling Li, Teri A. Manolio, Iftikhar J. Kullo, Christopher G. Chute, Rex L. Chisholm, Eric B. Larson, Catherine A. McCarty, Daniel R. Masys, Dan M. Roden, Mariza de Andrade. (2011) Variants Near FOXE1 Are Associated with Hypothyroidism and Other Thyroid Conditions: Using Electronic Medical Records for Genome- and Phenome-wide Studies. The American Journal of Human Genetics 89:4, 529-542
    

33. 33

    J.-L. Wémeau, J.-L. Sadoul, M. d’Herbomez, H. Monpeyssen, J. Tramalloni, E. Leteurtre, F. Borson-Chazot, P. Caron, B. Carnaille, J. Léger, C. Do, M. Klein, I. Raingeard, R. Desailloud, L. Leenhardt. (2011) Guidelines of the French society of endocrinology for the management of thyroid nodules. Annales d'Endocrinologie 72:4, 251-281
    

34. 34

    Kouki Mori, Katsumi Yoshida, Keiko Ishii, Kazuki Morohoshi, Yoshinori Nakagawa, Saeko Hoshikawa, Hiroshi Ozaki, Yurie Takahashi, Sadayoshi Ito. (2011) Experimental autoimmune thyroiditis in human parvovirus B19 transgenic mice. Autoimmunity 44:6, 483-489
    

35. 35

    Kazuki Morohoshi, Michiko Osone, Katsumi Yoshida, Yoshinori Nakagawa, Saeko Hoshikawa, Hiroshi Ozaki, Yurie Takahashi, Sadayoshi Ito, Kouki Mori. (2011) The sphingosine 1-phosphate receptor modulator FTY720 prevents iodide-induced autoimmune thyroiditis in non-obese diabetic mice. Autoimmunity 44:6, 490-495
    

36. 36

    S Danielides, CP Mavragani, I Katsakoulas, E Zintzaras, AA Drosos, PG Vlachoyiannopoulos, HM Moutsopoulos. (2011) Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma. Scandinavian Journal of Rheumatology 40:4, 299-303
    

37. 37

    Marc A. Seifman, Simon F. Grodski, Michael Bailey, Meei J. Yeung, Jonathan W. Serpell. (2011) Surgery in the setting of Hashimoto's thyroiditis. ANZ Journal of Surgery 81:7-8, 519-523
    

38. 38

    Federico Soriguer, Carolina Gutiérrez-Repiso, Elehazara Rubio-Martin, Francisca Linares, Isabel Cardona, Jaime López-Ojeda, Marta Pacheco, Stella González-Romero, Maria J. Garriga, Ines Velasco, Piedad Santiago, Eduardo García-Fuentes. (2011) Iodine intakes of 100–300 μg/d do not modify thyroid function and have modest anti-inflammatory effects. British Journal of Nutrition 105:12, 1783-1790
    

39. 39

    Louis C. Chen, Jennifer B. Green. (2011) First Reported Case of Unilateral Graves' Disease in the Left Lobe of a Bilobar Thyroid Gland. Thyroid 21:6, 683-686
    

40. 40

    N. Paul Ohori, Karen E. Schoedel. (2011) Thyroid Cytology: Challenges in the Pursuit of Low-Grade Malignancies. Radiologic Clinics of North America 49:3, 435-451
    

41. 41

    Natsuko Watanabe, Jaeduk Y. Noh, Hiroto Narimatsu, Kengo Takeuchi, Takuhiro Yamaguchi, Kaori Kameyama, Kazuhiko Kobayashi, Masahiro Kami, Atsushi Kubo, Yo Kunii, Taeko Shimizu, Koji Mukasa, Fumiko Otsuka, Ayako Miyara, Akinobu Minagawa, Koichi Ito, Kunihiko Ito. (2011) Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24 553 patients with Hashimoto’s disease. British Journal of Haematology 153:2, 236-243
    

42. 42

    Jin Wu, Cheng Fa-Xiang, Xiao Mei-Sun, Fan Yang, Dong Wang. (2011) Concurrent occurrence of chronic lymphocytic thyroiditis with hypothyroidism and growth hormone deficiency in a Turner’s syndrome patient. Journal of Pediatric Endocrinology and Metabolism 24:3-4, 237-239
    

43. 43

    Murat Doğan, Emel Acikgoz, Mehmet Acikgoz, Yasar Cesur, Sevil Ariyuca, Mehmet Selcuk Bektas. (2011) The frequency of Hashimoto thyroiditis in children and the relationship between urinary iodine level and Hashimoto thyroiditis. Journal of Pediatric Endocrinology and Metabolism 24:1-2, 75-80
    

44. 44

    Sibel Uncu, Savaş Yaylı, Sevgi Bahadır, Ayşenur Ökten, Köksal Alpay. (2011) Relevance of autoimmune thyroiditis in children and adolescents with vitiligo. International Journal of Dermatology 50:2, 175-179
    

45. 45

    Toshio Kahara, Noriko Iwaki, Hiroyasu Kaya, Toshiro Kurokawa, Takashi Yoshida, Kazuhide Ishikura, Rika Usuda. (2011) Transition of thyroid autoantibodies by rituximab treatment for thyroid MALT lymphoma. Endocrine Journal 58:1, 7-12
    

46. 46

    Catherine E. Pesce, Martha A. Zeiger. Management of Thyroiditis. In: Current Surgical Therapy. Elsevier, 2011:591-594.
    

47. 47

    Marco Cappa, Carla Bizzarri, Francesca Crea. (2011) Autoimmune Thyroid Diseases in Children. Journal of Thyroid Research 2011, 1-13
    

48. 48

    George Wilson, Arshag Mooradian, Irene Alexandraki, George Samrai. Endocrinology. In: Textbook of Family Medicine. Elsevier, 2011:756-801.
    

49. 49

    Nieves Arias, Óscar Moreno-Pérez, Evangelina Boix, Joaquín Serrano, Paula Revert, Víctor L. González, Ruth Sánchez-Ortiga, Antonio M. Picó. (2011) Response to adjuvant therapy with potassium perchlorate in amiodarone-induced thyrotoxicosis: observations on three cases. Endocrinología y Nutrición (English Edition) 58:3, 121-126
    

50. 50

    Ebru Akgul, Utku Kutuk, Sibel Ertek, Mustafa Cesur, Sengul Cehreli, Hasan Fehmi Tore, Gurbuz Erdogan. (2011) Cardiac Autonomic Function and Global Left Ventricular Performance in Autoimmune Eauthyroid Chronic Thyroiditis: Is Treatment Necessary at the Euthyroid Stage?. Echocardiography 28:1, 15-21
    

51. 51

    Aristo Vojdani. (2011) The Characterization of the Repertoire of Wheat Antigens and Peptides Involved in the Humoral Immune Responses in Patients with Gluten Sensitivity and Crohn's Disease. ISRN Allergy 2011, 1-12
    

52. 52

    Elaine Ron, Alina Brenner. (2010) Non-malignant Thyroid Diseases after a Wide Range of Radiation Exposures. Radiation Research 174:6b, 877-888
    

53. 53

    Margherita Sisto, Liana Cucci, Massimo D'Amore, Thomas C. Dow, Vincenzo Mitolo, Sabrina Lisi. (2010) Proposing a relationship between Mycobacterium avium subspecies paratuberculosis infection and Hashimoto's thyroiditis. Scandinavian Journal of Infectious Diseases 42:10, 787-790
    

54. 54

    Kouki Mori, Katsumi Yoshida. (2010) Viral infection in induction of Hashimotoʼs thyroiditis: a key player or just a bystander?. Current Opinion in Endocrinology, Diabetes and Obesity 17:5, 418-424
    

55. 55

    Danilo B. Höfling, Maria Cristina Chavantes, Adriana G. Juliano, Giovanni G. Cerri, Rossana Romão, Elisabeth Mateus Yoshimura, Maria Cristina Chammas. (2010) Low-level laser therapy in chronic autoimmune thyroiditis: A pilot study. Lasers in Surgery and Medicine 42:6, 589-596
    

56. 56

    Huy A. Tran, Glenn E. M. Reeves, Tim J. Lyons, John R. Attia. (2010) Histopathologic Findings of Autoimmunity in Thyroid, Pituitary, and Adrenal Diseases in Chronic Hepatitis C Postmortem Cases. Endocrine Practice 16:4, 566-569
    

57. 57

    R. K. Marwaha, N. Tandon, A. Desai, R. Kanwar, K. Mani. (2010) Iodine nutrition in upper socioeconomic school children of Delhi. Indian Pediatrics 47:4, 335-338
    

58. 58

    Ana Lleo, Pietro Invernizzi, Bin Gao, Mauro Podda, M. Eric Gershwin. (2010) Definition of human autoimmunity — autoantibodies versus autoimmune disease. Autoimmunity Reviews 9:5, A259-A266
    

59. 59

    H. Thude, S. Weißenborn, C. Vilser, U.A. Müller, C. Kloos, G. Wolf, J. Beck, D. Barz. (2010) No association between transmembrane protein–tyrosine–phosphatase receptor type C (CD45) exon A 77C>G transversion and Hashimoto's thyroiditis in a German population. Human Immunology 71:2, 220-223
    

60. 60

    Sławomir Rudzki, Mariusz Matuszek, Andrzej Nowakowski, Beata Matuszek, Przemysław Matras, Katarzyna Wojewoda. (2010) Own Experience in Treatment of Autoimmune Goiter in the Last Decade. Polish Journal of Surgery 82:2, 63-68
    

61. 61

    Jae-O Bae, Michael A. Skinner. ENDOCRINE DISORDERS AND TUMORS. In: Ashcraft's Pediatric Surgery. Elsevier, 2010:1037-1054.
    

62. 62

    J. M. Chehade, W. Lim, A. B. Silverberg, A. D. Mooradian. (2010) The incidence of Hashimotoâs disease in nodular goitre: the concordance in serological and cytological findings. International Journal of Clinical Practice 64:1, 29-33
    

63. 63

    M. Ladsous. Hypothyroïdie de l'adulte. In: Les maladies de la thyroïde. Elsevier, 2010:103-113.
    

64. 64

    Clarice Umbelino de Freitas, Rosária A. Grimaldi Campos, Mirta Alcira F. Rodrigues Silva, Maria Rosana I. Panachão, Jose Cássio de Moraes, William Waissmann, Antônio Roberto Chacra, Marina Y.S. Maeda, Regina S. Minazzi Rodrigues, James Gonçalves Belchor, Sonia Oliveira Barbosa, Raimunda Telma M. Santos. (2010) Can living in the surroundings of a petrochemical complex be a risk factor for autoimmune thyroid disease?. Environmental Research 110:1, 112-117
    

65. 65

    Carla Estaquio, Pierre Valeix, Laurence Leenhardt, Elizabeth Modigliani, Marie-Christine Boutron-Ruault, Laurence Chérié-Challine, Marguerite Legrand, Serge Hercberg, Katia Castetbon. (2009) Serum thyrotropin and free thyroxine reference ranges as defined in a disease-free sample of French middle-aged adults. Clinical Chemistry and Laboratory Medicine 47:12, 1497-1505
    

66. 66

    Eric Cheung, Howard A. Liebman. (2009) Thyroid Disease in Patients with Immune Thrombocytopenia. Hematology/Oncology Clinics of North America 23:6, 1251-1260
    

67. 67

    Kostas Kakleas, Evangelia Paschali, Nikos Kefalas, Aspasia Fotinou, Maria Kanariou, Christina Karayianni, Kyriaki Karavanaki. (2009) Factors for thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Upsala Journal of Medical Sciences 114:4, 214-220
    

68. 68

    Cristiano Alessandri, Fabrizio Conti, Paola Conigliaro, Riccardo Mancini, Laura Massaro, Guido Valesini. (2009) Seronegative Autoimmune Diseases. Annals of the New York Academy of Sciences 1173:1, 52-59
    

69. 69

    G. A. Nevinsky, V. N. Buneva. (2009) Peculiarities of abzymes from sera and milk of healthy donors and patients with autoimmune and viral diseases. Biochemistry (Moscow) 74:9, 945-961
    

70. 70

    Yaqiong Li, Yanhua Bai, Zhiyan Liu, Takashi Ozaki, Emiko Taniguchi, Ichiro Mori, Koji Nagayama, Hirotoshi Nakamura, Kennichi Kakudo. (2009) Immunohistochemistry of IgG4 can help subclassify Hashimoto's autoimmune thyroiditis. Pathology International 59:9, 636-641
    

71. 71

    H. Demirbilek, N. Kandemir, E. N. Gonc, A. Ozon, A. Alikasifoglu. (2009) Assessment of thyroid function during the long course of Hashimoto's thyroiditis in children and adolescents. Clinical Endocrinology 71:3, 451-454
    

72. 72

    Magnus P. Stalder, Alicia Rovó, Jörg Halter, Dominik Heim, Tobias Silzle, Jakob Passweg, Johannes Rischewski, Martin Stern, Caroline Arber, Andreas Buser, Sandrine Meyer-Monard, André Tichelli, Alois Gratwohl. (2009) Aplastic anemia and concomitant autoimmune diseases. Annals of Hematology 88:7, 659-665
    

73. 73

    Thyroid Gland Testing. In: Endocrine and Metabolic Disorders. CRC Press, 2009:1-58.
    

74. 74

    José Ignacio Jaén Díaz, Francisco López De Castro, Blanca Cordero García, Francisca Santillana Balduz, Julia Sastre Marcos, Cristina Martín Dal Gesso. (2009) Tiroiditis posparto: incidencia y estudio de los posibles factores asociados en las embarazadas de una zona de salud. Medicina Clínica 132:15, 569-573
    

75. 75

    Michael McDermott, E Ridgway. Hypothyroidism. In: Medical Management of Thyroid Disease, Second Edition. CRC Press, 2009:145-201.
    

76. 76

    Rafael Luboshitzky, Leonid Chervinsky, Ghali Qupti, Muralee Dharan. (2009) Cytodiagnostic Accuracy of Hashimoto Thyroiditis. The Endocrinologist 19:2, 55-57
    

77. 77

    E. LAHNER, B. ANNIBALE, G. DELLE FAVE. (2009) Systematic review: Heliocobacter pylori infection and impaired drug absorption. Alimentary Pharmacology & Therapeutics 29:4, 379-386
    

78. 78

    Ronald A. DeLellis, Yuri E. Nikiforov. Thyroid and Parathyroid Glands. In: Diagnostic Surgical Pathology of the Head and Neck. Elsevier, 2009:563-646.
    

79. 79

    Ivan Bank, Jamiu O. Busari. (2008) Crohn’s disease, autoimmune thyroiditis, and beta-thalassemia trait in an adolescent: an unusual combination of diseases. European Journal of Pediatrics 167:11, 1343-1346
    

80. 80

    L.-D. Xie, Y. Gao, M.-R. Li, G.-Z. Lu, X.-H. Guo. (2008) Distribution of immunoglobulin G subclasses of anti-thyroid peroxidase antibody in sera from patients with Hashimoto's thyroiditis with different thyroid functional status. Clinical & Experimental Immunology 154:2, 172-176
    

81. 81

    Udara Wijeyesinghe, Anthony S. Russell. (2008) Outcome of high titer antinuclear antibody positivity in individuals without connective tissue disease: a 10-year follow-up. Clinical Rheumatology 27:11, 1399-1402
    

82. 82

    Xavier Serres-Créixams, Ignasi Castells-Fusté, Xavier Pruna-Comella, Victorina Yetano-Laguna, Victòria Garriga-Farriol, Elena Gallardo-Agromayor. (2008) Paratracheal lymph nodes: A new sonographic finding in autoimmune thyroiditis. Journal of Clinical Ultrasound 36:7, 418-421
    

83. 83

    Zhiping Sun, Weixue Zhong, Xiang Lu, Bimin Shi, Yibei Zhu, Lei Chen, Guangbo Zhang, Xueguang Zhang. (2008) Association of Graves’ Disease and Prevalence of Circulating IFN-γ-producing CD28− T Cells. Journal of Clinical Immunology 28:5, 464-472
    

84. 84

    Jacqueline Araujo, Lucas AC Brandão, Rafael L Guimarães, Sérgio Santos, Elcy A Falcão, Michele Milanese, Ludovica Segat, Paulo R Souza, José Luiz de Lima-Filho, Sergio Crovella. (2008) Prevalence of autoimmune thyroid disease and thyroid dysfunction in young Brazilian patients with type 1 diabetes. Pediatric Diabetes 9:4pt1, 272-276
    

85. 85

    Hiroshi E. Takami, Rika Miyabe, Kaori Kameyama. (2008) Hashimoto’s Thyroiditis. World Journal of Surgery 32:5, 688-692
    

86. 86

    B AKINCI, A COMLEKCI, S YENER, F BAYRAKTAR, T DEMIR, M OZCAN, F YUKSEL, S YESIL. (2008) Hashimoto's Thyroiditis, but not Treatment of Hypothyroidism, Is Associated with Altered TGF-β1 Levels. Archives of Medical Research 39:4, 397-401
    

87. 87

    M. Štefanić, S. Papić, M. Suver, L. Glavaš-Obrovac, I. Karner. (2008) Association of vitamin D receptor gene 3'-variants with Hashimoto's thyroiditis in the Croatian population. International Journal of Immunogenetics 35:2, 125-131
    

88. 88

    Satoshi Murao, Shiori Kondo, Jun Ohashi, Yasuhisa Fujii, Ikki Shimizu, Masao Fujiyama, Keizo Ohno, Yasuharu Takada, Kazuaki Nakai, Yukio Yamane, Haruhiko Osawa, Hideichi Makino. (2008) Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)—A 5-year follow-up of the Ehime study. Diabetes Research and Clinical Practice 80:1, 114-121
    

89. 89

    Edith Lahner, Marco Centanni, Giacoma Agnello, Lucilla Gargano, Lucy Vannella, Carlo Iannoni, Gianfranco Delle Fave, Bruno Annibale. (2008) Occurrence and Risk Factors for Autoimmune Thyroid Disease in Patients with Atrophic Body Gastritis. The American Journal of Medicine 121:2, 136-141
    

90. 90

    Ichiro Yabe, Kazunori Sato, Hiroyuki Soma, Hidenao Sasaki. (2008) Progressive cerebellar ataxia with euthyroid Hashimoto's disease -Implication of autoantibodies associated with Hashimoto's disease in progressive cerebellar ataxia-. Rinsho Shinkeigaku 48:9, 640-645
    

91. 91

    Hee-Kyung Kim, Hong-Joon Shin, Ho-Cheol Kang. (2008) A Case of Painful Hashimoto's Thyroiditis Successfully Treated with Total Thyroidectomy. Journal of Korean Endocrine Society 23:6, 438
    

92. 92

    Roberto Bei, Laura Masuelli, Camilla Palumbo, Ilaria Tresoldi, Antonio Scardino, Andrea Modesti. (2008) Long-Lasting Tissue Inflammatory Processes Trigger Autoimmune Responses to Extracellular Matrix Molecules. International Reviews of Immunology 27:3, 137-175
    

93. 93

    Slavica Markovic, Gordana Kostic, Zoran Igrutinovic, Biljana Vuletic. (2008) Hashimoto's thyroiditis in children and adolescents. Srpski arhiv za celokupno lekarstvo 136:5-6, 262-266
    

94. 94

    Corrado Betterle, Fabio Presotto. Chapter 12 Autoimmune Polyendocrine Syndromes (APS) or Multiple Autoimmune Syndromes (MAS). Elsevier, 2008:135-148.
    

95. 95

    Robert J. McConnell, Alina V. Brenner, Valery A. Oliynyk, Jacob Robbins, Galyna M. Terekhova, Daniel J. Fink, Ovsiy V. Epshtein, Maureen Hatch, Victor M. Shpak, A. Bertrand Brill, Yevgeniy A. Shelkovoy, Lydia B. Zablotska, Ihor J. Masnyk, Geoffrey R. Howe, Mykola D. Tronko. (2007) Factors associated with elevated serum concentrations of anti-TPO antibodies in subjects with and without diffuse goitre. Results from the Ukrainian-American Cohort Study of Thyroid Cancer and Other Thyroid Diseases Following the Chornobyl Accident. Clinical Endocrinology 67:6, 879-890
    

96. 96

    Julieta Gerenova, Veselina Gadjeva. (2007) Oxidative stress and antioxidant enzyme activities in patients with Hashimoto’s thyroiditis. Comparative Clinical Pathology 16:4, 259-264
    

97. 97

    Olga Kordonouri, Reinhard Hartmann, Thomas Riebel, Klaus-Peter Liesenkoetter. (2007) Early treatment with l-thyroxine in children and adolescents with type 1 diabetes, positive thyroid antibodies, and thyroid gland enlargement. Pediatric Diabetes 8:4, 180-184
    

98. 98

    Takahiro Zenda, Kunihiko Yokoyama, Hiroshi Minato, Takaharu Masunaga, Kimihide Shinozaki. (2007) A Variant of Thyrotoxicosis Associated with Chronic Thyroiditis Characterized by Prolonged Fever, Absence of Anti-Thyroidal Antibodies, and Favorable Response to Naproxen. The American Journal of the Medical Sciences 333:5, 305-308
    

99. 99

    Yen-Kung Chen, Yen-Ling Chen, Ru-Hwa Cheng, Chia-Lu Yeh, Chin-Cheng Lee, Chung-Huei Hsu. (2007) The significance of FDG uptake in bilateral thyroid glands. Nuclear Medicine Communications 28:2, 117-122
    

100. 100

     Olaf Hiort, Thomas Michael Kapellen, Roland Pfäffle, Klemens Raile, Helmut Willgerodt. Erkrankungen der endokrinen Drüsen inkl. Diabetes und Wachstumsstörungen. In: Therapie in der Kinder- und Jugendmedizin. Elsevier, 2007:535-593.
     

101. 101

     Suzan Tabur, Ozgur Yasar, Ahmet O. Koylu, Tevfik Sabuncu. (2007) Sensitivity and Specificity of Ultrasonography in Detecting Thyroiditis. The Endocrinologist 17:1, 5-6
     

102. 102

     Ronald C W Ma, Alice P S Kong, Norman Chan, Peter C Y Tong, Juliana C N Chan. (2007) Drug-Induced Endocrine and Metabolic Disorders. Drug Safety 30:3, 215-245
     

103. 103

     Robertas Bunevicius, Jurate Peceliuniene, Narseta Mickuviene, Adomas Bunevicius, Victor J. Pop, Susan S. Girdler. (2007) Mood and thyroid immunity assessed by ultrasonographic imaging in a primary health care. Journal of Affective Disorders 97:1-3, 85-90
     

104. 104

     Usha Kini. (2007) Role of fine needle aspiration cytology in thyroiditis. Expert Review of Clinical Immunology 3:1, 85-99
     

105. 105

     Mehmet Bastemir, Rifat Emral, Gurbuz Erdogan, Sevim Gullu. (2006) High Prevalence of Thyroid Dysfunction and Autoimmune Thyroiditis in Adolescents after Elimination of Iodine Deficiency in the Eastern Black Sea Region of Turkey. Thyroid 16:12, 1265-1271
     

106. 106

     N. A. Karataeva, V. N. Buneva, G. A. Nevinsky. (2006) Polysaccharide kinase activity of human milk IgG antibodies. Biochemistry (Moscow) 71:11, 1207-1221
     

107. 107

     Brian M. Casey, Kenneth J. Leveno. (2006) Thyroid Disease in Pregnancy. Obstetrics & Gynecology 108:5, 1283-1292
     

108. 108

     V. Forman-Hoffman, R. A. Philibert. (2006) Lower TSH and higher T4 levels are associated with current depressive syndrome in young adults. Acta Psychiatrica Scandinavica 114:2, 132-139
     

109. 109

     A. Laroni, M. Calabrese, P. Perini, M. P. Albergoni, F. Ranzato, M. Tiberio, L. Battistin, P. Gallo. (2006) Multiple sclerosis and autoimmune diseases. Journal of Neurology 253:5, 636-639
     

110. 110

     M.R. Helvaci ., F. Ozcura ., A. Ozkan ., H. Dayioglu .. (2006) What a High Prevalence of Autoimmune Thyroiditis and Thyroidectomy in Women. Journal of Medical Sciences(Faisalabad) 6:4, 654-657
     

111. 111

     Natal’ya A. Karataeva, Dmitry Gorbunov, Ivan V. Prokudin, Valentina N. Buneva, Anna A. Kulminskaya, Kirill N. Neustroev, Georgy A. Nevinsky. (2006) Human milk antibodies with polysaccharide kinase activity. Immunology Letters 103:1, 58-67
     

112. 112

     Johan Svensson, Bengt Lindberg, Ulla-Britt Ericsson, Per Olofsson, Björn Jonsson, Sten-Anders Ivarsson. (2006) Thyroid Autoantibodies in Cord Blood Sera from Children and Adolescents with Autoimmune Thyroiditis. Thyroid 16:1, 79-83
     

113. 113

     Najdana Gligorovic. (2006) Markers of thyroid autoimmunity. Jugoslovenska medicinska biohemija 25:4, 373-379
     

114. 114

     Elena Lopez-Rangel, Peter N. Malleson, David S. Lirenman, Benjamin Roa, Joanna Wiszniewska, M.E. Suzanne Lewis. (2005) Systemic lupus erythematosus and other autoimmune disorders in children with Noonan syndrome. American Journal of Medical Genetics Part A 139A:3, 239-242
     

115. 115

     Stephen C Dreskin, Karen Y Andrews. (2005) The thyroid and urticaria. Current Opinion in Allergy and Clinical Immunology 5:5, 408-412
     

116. 116

     D GORBUNOV, N KARATAEVA, V BUNEVA, G NEVINSKY. (2005) Lipid kinase activity of antibodies from milk of clinically healthy human mothers. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1735:3, 153-166
     

117. 117

     Talia Kakourou, Christina Kanaka-Gantenbein, Anna Papadopoulou, Eirini Kaloumenou, George P. Chrousos. (2005) Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo. Journal of the American Academy of Dermatology 53:2, 220-223
     

118. 118

     Catharina Brömel, Rachel E. Pollard, Philip H. Kass, Valerie F. Samii, Autumn P. Davidson, Richard W. Nelson. (2005) Ultrasonographic Evaluation of the Thyroid Gland in Healthy, Hypothyroid, and Euthyroid Golden Retrievers with Nonthyroidal Illness. Journal of Veterinary Internal Medicine 19:4, 499-506
     

119. 119

     Rui Lu, Kenneth D. Burman, Jacqueline Jonklaas. (2005) Transient Graves' Hyperthyroidism During Pregnancy in a Patient with Hashimoto's Hypothyroidism. Thyroid 15:7, 725-729
     

120. 120

     Mary E. Charlson, Jwala Karnik, Mitchell Wong, Charles E. McCulloch, James P. Hollenberg. (2005) Does Experience Matter?. A Comparison of the Practice of Attendings and Residents. Journal of General Internal Medicine 20:6, 497-503
     

121. 121

     Hidemi Ohye, Shuji Fukata, Sumihisa Kubota, Ichiro Sasaki, Yuki Takamura, Fumio Matsuzuka, Nobuyuki Amino, Kanji Kuma, Akira Miyauchi, Kennichi Kakudo. (2005) Successful Treatment for Recurrent Painful Hashimoto's Thyroiditis by Total Thyroidectomy. Thyroid 15:4, 340-345
     

122. 122

     Josko Bulum, Nikica Car, Lea Smircic-Duvnjak, Sonja Gracin, Zeljko Metelko. (2005) Takayasu?s arteritis and chronic autoimmune thyroiditis in a patient with type 1 diabetes mellitus. Clinical Rheumatology 24:2, 169-171
     

123. 123

     Vahab Fatourechi. (2005) Hashimoto's encephalopathy: myth or reality? An endocrinologist's perspective. Best Practice & Research Clinical Endocrinology & Metabolism 19:1, 53-66
     

124. 124

     Mark F. Prummel, Wilmar M. Wiersinga. (2005) Thyroid peroxidase autoantibodies in euthyroid subjects. Best Practice & Research Clinical Endocrinology & Metabolism 19:1, 1-15
     

125. 125

     Robert Heymann, Gregory A. Brent. (2005) RAPID PROGRESSION FROM SUBCLINICAL TO SYMPTOMATIC OVERT HYPOTHYROIDISM. Endocrine Practice 11:2, 115-119
     

126. 126

     Michael T. Stang, John H. Yim. Autoimmunity — Endocrine. In: Measuring Immunity. Elsevier, 2005:543-559.
     

127. 127

     Duygu Yazgan AKSOY, Ulku KERIMOGLU, Hamza OKUR, Hande CANPINAR, Ergun KARAAGAOGLU, Sevgi YETGIN, Emin KANSU, Olcay GEDIK. (2005) Effects of Prophylactic Thyroid Hormone Replacement in Euthyroid Hashimoto's Thyroiditis. Endocrine Journal 52:3, 337-343
     

128. 128

     T. Raupach, M. Karaus. (2004) Pharyngitis, Sturzsenkung und Hyperthyreose bei einer 71-jhrigen Patientin. Der Internist 45:10, 1182-1188
     

129. 129

     Sonia Quaratino, Ester Badami, Yun Yun Pang, Istvan Bartok, Julian Dyson, Dimitris Kioussis, Marco Londei, Luigi Maiuri. (2004) Degenerate self-reactive human T-cell receptor causes spontaneous autoimmune disease in mice. Nature Medicine 10:9, 920-926
     

130. 130

     A Gasbarri, S Sciacchitano, A Marasco, M Papotti, A Di Napoli, A Marzullo, P Yushkov, L Ruco, A Bartolazzi. (2004) Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis. British Journal of Cancer
     

131. 131

     C. Betterle, F. Lazzarotto, F. Presotto. (2004) Autoimmune polyglandular syndrome Type 2: the tip of an iceberg?. Clinical & Experimental Immunology 137:2, 225-233
     

132. 132

     Leonardo Punzi, Corrado Betterle. (2004) Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine 71:4, 275-283
     

133. 133

     L.F. Pallardo Snchez, . Villarroel Bajo. (2004) Tiroiditis. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 9:14, 838-845
     

134. 134

     Johan Svensson, Bengt Lindberg, Björn Jonsson, Ulla-Britt Ericsson, Per Olofsson, Heikki Hyöty, Sten A. Ivarsson. (2004) Intrauterine Exposure to Maternal Enterovirus Infection as a Risk Factor for Development of Autoimmune Thyroiditis During Childhood and Adolescence. Thyroid 14:5, 367-370
     

135. 135

     Caroline GP Roberts, Paul W Ladenson. (2004) Hypothyroidism. The Lancet 363:9411, 793-803
     

136. 136

     Rita Rizzi, Domenico Pastore, Arcangelo Liso, Grazia M Liuzzi, Anna M Dalena, Giorgina Specchia, Rosalia Ricco, Vincenzo Liso. (2004) Autoimmune Myelofibrosis: Report of Three Cases and Review of the Literature. Leukemia & Lymphoma 45:3, 561-566
     

137. 137

     F. Duron, E. Dubosclard, E. Ballot, C. Johanet. (2004) Thyroïdites. EMC - Endocrinologie - Nutrition 1:1, 1-10
     

138. 138

     J.A. López Medina, R. López-Jurado Romero de la Cruz, A. Delgado García, R. Espigares Martín, J.L. Barrionuevo Porras, L. Ortega Martos. (2004) Autoinmunidad pancreática, tiroidea y relacionada con la celiaquía en niños con diabetes mellitus tipo 1. Anales de Pediatría 61:4, 320-325
     

139. 139

     Frdrique d'Arbonneau, Sverine Ansart, Rozenn Le Berre, Maryvonne Dueymes, Pierre Youinou, Yvon-Louis Pennec. (2003) Thyroid dysfunction in primary Sjgren's syndrome: A long-term followup study. Arthritis & Rheumatism 49:6, 804-809
     

140. 140

     Gherardo Mazziotti, Francesca Sorvillo, Sergio Iorio, Antonella Carbone, Antonio Romeo, Marco Piscopo, Salvatore Capuano, Ermanno Capuano, Giovanni Amato, Carlo Carella. (2003) Grey-scale analysis allows a quantitative evaluation of thyroid echogenicity in the patients with Hashimoto's thyroiditis. Clinical Endocrinology 59:2, 223-229
     

141. 141

     Hans Carl Hasselbalch. (2003) B-cell depletion with rituximab—a targeted therapy for Graves’ disease and autoimmune thyroiditis. Immunology Letters 88:1, 85-86
     

142. 142

     Pearce , Elizabeth N. , Farwell , Alan P. , Braverman , Lewis E. , . (2003) Thyroiditis. New England Journal of Medicine 348:26, 2646-2655
     Full Text

143. 143

     Douglas R. Mitchell, Curtis A. Parvin, Ann M. Gronowski. (2003) Rules-based detection of discrepancies between TSH and free T4 results. Clinica Chimica Acta 332:1-2, 89-94
     

144. 144

     Christos Zois, Ioanna Stavrou, Chrysoula Kalogera, Eugenia Svarna, Ioannis Dimoliatis, Konstantinos Seferiadis, Agathocles Tsatsoulis. (2003) High Prevalence of Autoimmune Thyroiditis in Schoolchildren After Elimination of Iodine Deficiency in Northwestern Greece. Thyroid 13:5, 485-489
     

145. 145

     R.K. Marwaha, Saurav Sen, Nikhil Tandon, M. Sahoo, R.P. Walia, Satvir Singh, S.K. Ganguly, S.K. Jain. (2003) Familial Aggregation of Autoimmune Thyroiditis in First-Degree Relatives of Patients with Juvenile Autoimmune Thyroid Disease. Thyroid 13:3, 297-300
     

146. 146

     Michael B. Zimmermann, Diego Moretti, Noureddine Chaouki, Toni Torresani. (2003) Introduction of Iodized Salt to Severely Iodine-Deficient Children Does Not Provoke Thyroid Autoimmunity: A One-Year Prospective Trial in Northern Morocco. Thyroid 13:2, 199-203
     

147. 147

     A. González, F. Pereyra-García, I. Marañés, I. Llorente. (2003) Hemiagenesia tiroidea asociada a tiroiditis crónica autoinmune. Endocrinología y Nutrición 50:5, 178-179
     

148. 148

     A.I. Revilla Grande, O. Revilla Grande, A.I. García Valiente, P. Pérez Polo. (2003) Diagnóstico de hipotiroidismo subclínico en atención primaria y derivación a atención especializada. Atención Primaria 32:1, 63
     

149. 149

     Wolfgang Raber, Alois Gessl, Peter Nowotny, Heinrich Vierhapper. (2002) Thyroid Ultrasound Versus Antithyroid Peroxidase Antibody Determination: A Cohort Study of Four Hundred Fifty-One Subjects. Thyroid 12:8, 725-731
     

150. 150

     Loukas Gourgiotis, Nicholas J. Sarlis, Nahrain Al-Zubaidi, Monica C. Skarulis, Steven K. Libutti, H. Richard Alexander ., Maria J. Merino, Loukas Gourgiotis, Nahrain Al-Zubaidi. (2002) SUCCESSFUL OUTCOME AFTER SURGICAL MANAGEMENT IN TWO CASES OF THE "PAINFUL VARIANT" OF HASHIMOTO'S THYROIDITIS. Endocrine Practice 8:4, 259-265
     

151. 151

     O. Kordonouri, D. Deiss, T. Danne, A. Dorow, C. Bassir, A. Gruters-Kieslich. (2002) Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with Type 1 diabetes. Diabetic Medicine 19:6, 518-521
     

152. 152

     Scott Sloka. (2002) Observations on Recent Studies Showing Increased Co-occurrence of Autoimmune Diseases. Journal of Autoimmunity 18:3, 251-257
     

153. 153

     C. BETTERLE, A. FUSARI, F. PRESOTTO, C. DAL PRA, B. PEDINI, F. LAZZAROTTO, R. ZANCHETTA. (2002) Pancreatic Autoantibodies in Italian Patients with Newly Diagnosed Type 1 Diabetes Mellitus under the Age of 20 Years. Annals of the New York Academy of Sciences 958:1, 271-275
     

154. 154

     A. Van den Bruel, M. Drijkoningen, R. Oyen, E. Vanfleteren, R. Bouillon. (2002) Diagnostic Fine-Needle Aspiration Cytology and Immunocytochemistry Analysis of a Primary Thyroid Lymphoma Presenting as an Anatomic Emergency. Thyroid 12:2, 169-173
     

155. 155

     Raymond F. Nachreiner, Kent R. Refsal, Peter A. Graham, Mark M. Bowman. (2002) Prevalence of serum thyroid hormone autoantibodies in dogs with clinical signs of hypothyroidism. Journal of the American Veterinary Medical Association 220:4, 466-471
     

156. 156

     José Antonio Carneros, Constanza Ciriza, Óscar Urquiza, Saleh Dajil. (2002) Enfermedad de Crohn en paciente diagnosticada de tiroiditis de Hashimoto y síndrome de Sjögren. Medicina Clínica 119:2, 78-79
     

157. 157

     Bharath Srivatsa, Sumathi Srivatsa, Kirby L Johnson, Osamu Samura, Stephanie L Lee, Diana W Bianchi. (2001) Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. The Lancet 358:9298, 2034-2038
     

158. 158

     David Leslie, Peter Lipsky, Abner Louis Notkins. (2001) Autoantibodies as predictors of disease. Journal of Clinical Investigation 108:10, 1417-1422
     

159. 159

     David Leslie, Peter Lipsky, Abner Louis Notkins. (2001) Autoantibodies as predictors of disease. Journal of Clinical Investigation 108:10, 1417-1422
     

160. 160

     Hideaki Miwa, Tetsuya Takakuwa, Shin-ichi Nakatsuka, Yasuhiko Tomita, Fumio Matsuzuka, Katsuyuki Aozasa. (2001) DNA Sequence of Immunoglobulin Heavy Chain Variable Region Gene in Thyroid Lymphoma. Cancer Science 92:10, 1041-1047
     

161. 161

     Michael T. McDermott, Bryan R. Haugen, Dennis C. Lezotte, Stacey Seggelke, E. Chester Ridgway. (2001) Management Practices Among Primary Care Physicians and Thyroid Specialists in the Care of Hypothyroid Patients. Thyroid 11:8, 757-764
     

162. 162

     Gilbert H. Daniels. (2001) Atypical Subacute Thyroiditis: Preliminary Observations. Thyroid 11:7, 691-695
     

163. 163

     James D. Bretz, James R. Baker. (2001) Apoptosis and autoimmune thyroid disease: following a TRAIL to thyroid destruction? .. Clinical Endocrinology 55:1, 1-11
     

164. 164

     Penelope J Hunt, John AH Wass. Thyroid Disease. In: eLS. John Wiley & Sons, Ltd, 2001.
     

165. 165

     Ponnusamy Saravanan, Colin M. Dayan. (2001) THYROID AUTOANTIBODIES. Endocrinology and Metabolism Clinics of North America 30:2, 315-337
     

166. 166

     N. Sera, A. Kawakami, T. Nakashima, H. Nakamura, M. Imaizumi, T. Koji, Y. Abe, T. Usa, T. Tominaga, E. Ejima, K. Ashizawa, N. Yokoyama, N. Ishikawa, K. Ito, K. Eguchi. (2001) Fas/FasL mediated apoptosis of thyrocytes in Graves' disease. Clinical and Experimental Immunology 124:2, 197-207
     

167. 167

     S. Padberg, K. Heller, K.H. Usadel, P.-M. Schumm-Draeger. (2001) One-Year Prophylactic Treatment of Euthyroid Hashimoto's Thyroiditis Patients with Levothyroxine: Is There a Benefit?. Thyroid 11:3, 249-255
     

168. 168

     Colin M Dayan. (2001) Interpretation of thyroid function tests. The Lancet 357:9256, 619-624
     

169. 169

     Hiroko Yamazaki, James D. Bretz, Patricia L. Arscott, James R. Baker. (2000) Apoptosis and the thyroid: the biology and potential implications for thyroid disease. Current Opinion in Endocrinology & Diabetes 7:5, 260-264
     

170. 170

     Lilah F. Morris, Alan D. Waxman, Glenn D. Braunstein. (2000) Accuracy Considerations When Using Early (Four- or Six-Hour) Radioactive Iodine Uptake to Predict Twenty-Four-Hour Values for Radioactive Iodine Dosage in the Treatment of Graves' Disease. Thyroid 10:9, 779-787
     

171. 171

     F.F. Palazzo, L.J. Hammond, A.W. Goode, R. Mirakian. (2000) Death of the Autoimmune Thyrocyte: Is it Pushed or Does it Jump?. Thyroid 10:7, 561-572
     

172. 172

     Kimberly A Sabelko-Downes, John H Russell. (2000) The role of Fas ligand in vivo as a cause and regulator of pathogenesis. Current Opinion in Immunology 12:3, 330-335
     

173. 173

     Marc Michel, Jean-Charles Piette, Etienne Roullet, Françoise Duron, Camille Françès, Laurence Nahum, Nadège Pelletier, Isabelle Crassard, Sebastien Nunez, Catherine Michel, Jean-François Bach, Elisabeth Tournier-Lasserve. (2000) The R131 low-affinity allele of the Fc gamma RIIA receptor is associated with systemic lupus erythematosus but not with other autoimmune diseases in French Caucasians. The American Journal of Medicine 108:7, 580-583
     

174. 174

     R. Maile, K. A. Elsegood, T. C. Harding, J. B. Uney, C. E. H. Stewart, G. Banting, C. M. Dayan. (2000) Effective formation of major histocompatibility complex class II-peptide complexes from endogenous antigen by thyroid epithelial cells. Immunology 99:3, 367-374
     

175. 175

     Ole Martin Pedersen, Nils Petter Aardal, Trond Bjerke Larssen, Jan Erik Varhaug, Ole Myking, Harald Vik-Mo. (2000) The Value of Ultrasonography in Predicting Autoimmune Thyroid Disease. Thyroid 10:3, 251-259
     

176. 176

     J.A. Girón González, F. Guerrero Sánchez, F. Tellez Pérez. (2000) Tiroiditis. Medicine - Programa de Formación Médica Continuada Acreditado 8:17, 895-902
     

177. 177

     L. García García-Doncel, J. Ortego Rojo, F. Guerrero Sánchez. (2000) Hipotiroidismo. Medicine - Programa de Formación Médica Continuada Acreditado 8:18, 947-955
     

178. 178

     J.A. Girón González, A. Arizcorreta Yarza, F. Brun Romero. (2000) Caso clínico mujer joven con bocio de larga evolución. Medicine - Programa de Formación Médica Continuada Acreditado 8:17, 931-932
     

179. 179

     L. García García-Doncel, J. Ortego Rojo, F. Guerrero Sánchez. (2000) Protocolo diagnóstico del hipotiroidismo. Medicine - Programa de Formación Médica Continuada Acreditado 8:18, 974-976
     

180. 180

     C. Broussolle, M.P. Steineur, F. Bailly, F. Zoulim, C. Trépo. (1999) Infection par le virus de l'hépatite C et pathologies thyroïdiennes. La Revue de Médecine Interne 20:9, 766-773
     

181. 181

     YOH HIDAKA, MOTOSHI OKUMURA, SHUJI FUKATA, YUKI SHIMAOKA, KEIKO TAKEOKA, HIS ATO TADA, KANJI KUMA, NOBUYUKI AMINO. (1999) Increased Serum Concentration of Interleukin-12 in Patients with Silent Thyroiditis and Graves' Disease. Thyroid 9:2, 149-153
     

182. 182

     Santiago Díez, Helena Banias, José L. Díez-Martin, Montserrat Briz, Janvier Estrado, Balbino Barceló. (1999) Apparent cure of Graves-Basedow disease after sibling allogeneic bone marrow transplantation. Clinical Endocrinology 50:2, 267-270
     

183. 183

     C Guillen, A Prieto, C Alvarez Escola, E. Reyes, D. Diaz, E. Sanantonio, A. De La Hera, M Alvarez Mon. (1999) Abnormal Functiuonal Behavior of Peripheral Blood Mononuclear Cells from Hashimoto's Disease Patients. Immunomodulatory Effects of Cyclosporin A. Immunopharmacology and Immunotoxicology 21:1, 15-39
     

184. 184

     Samir A. Shah, Mark A. Peppercorn, Johanna A. Pallotta. (1998) Autoimmune (Hashimoto's) Thyroiditis Associated With Crohn's Disease. Journal of Clinical Gastroenterology 26:2, 117-120
     

185. 185

     BEATRIZ R. OLSON. (1998) Facets of Thyroid Disease in Women: Four Case Reports. Journal of Women's Health 7:1, 85-91
     

186. 186

     Stephanie B. Seminara, MD, Gilbert H. Daniels, MD, FACE. (1998) AMIODARONE AND THE THYROID. Endocrine Practice 4:1, 48-57
     

187. 187

     Carme Roura-Mir, Marta Catálfamo, Mireia Sospedra, Laura Alcalde, Ricardo Pujol-Borrell, Dolores Jaraquemada. (1997) Single-cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's and Graves' disease. European Journal of Immunology 27:12, 3290-3302
     

188. 188

     Sheshadri Narayana. (1997) Current concepts of thyroid function and laboratory evaluation. Indian Journal of Clinical Biochemistry 12:1, 25-34
     

189. 189

     NICHOLAS J. SARLIS, FRANÇOISE BRUCKER-DAVIS, JOSEPH P. SWIFT, KAZUO TAHARA, LEONARD D. KOHN. (1997) Graves' Disease Following Thyrotoxic Painless Thyroiditis. Analysis of Antibody Activities Against the Thyrotropin Receptor in Two Cases. Thyroid 7:6, 829-836
     

190. 190

     Hossein Gharib. (1997) CHANGING CONCEPTS IN THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES. Endocrinology and Metabolism Clinics of North America 26:4, 777-800
     

191. 191

     Ronald W. Pies. (1997) The diagnosis and treatment of subclinical hypothyroid states in depressed patients. General Hospital Psychiatry 19:5, 344-354
     

192. 192

     H. Mörk, F. Jakob, O. Al-Taie, A. M. Gassel, M. Scheurlen. (1997) Primary Biliary Cirrhosis and Gastric Carcinoid: A Rare Association?. Journal of Clinical Gastroenterology 24:4, 270-273
     

193. 193

     Colin M. Dayan, Kathryn A. Elsegood, Robert Maile. (1997) Pasl expression on epithelial cells: the Bottazzo-Feldmann hypothesis revisited. Immunology Today 18:5, 203
     

194. 194

     Lars E. French, Jürg Tschopp. (1997) Thyroiditis and hepatitis: Fas on the road to disease. Nature Medicine 3:4, 387-388
     

195. 195

     E. Gorez, I. Nakib, H. Larbre, N. Schneider, C. Schvartz, M.J. Delisle, B. Delemer, J. Caron, G. Thiéfin. (1997) Lack of epidemiological evidence for a link between thyroid auto-immune disease and hepatitis C virus infection. Journal of Hepatology 26:3, 738-739
     

196. 196

     Robert S Lindsay, Anthony D Toft. (1997) Hypothyroidism. The Lancet 349:9049, 413-417